Table Of Content

INDEXES TO VOLUME 57 Banchs I, 549 Bresolin N, 304, 373 Concha, L, 188 Author Banfi S, 777 Bressman SB, 596 Cook JE, 795 Bang OY, 874 Breteler MMB, 779, 789, Cooper ST, 42 Index Banwell B, 310, 327 928 Corbett MA, 42 Baram TZ, 152, 609 Breyer R, 758 Cornblath DR, 160 Barber PA, 848 Brice A, 505, 567 Corral J, 549 Barbot C, 513, 934 Briemberg HR, 664 Coslett HB, 721 Barker GJ, 622 Broggi G, 925 Coubes P, 738 Aasly JO, 762 Barker R, 564 Broich P, 457 Coutts SB, 848 Abbott RD, 98 Barkhof F, 327, 606 Bromberg MB, 704 Cox H, 310 Abi-Saab WM, 226 Barnett MH, 158 Brooks DJ, 634 Crain BJ, 610 Adachi H, 236 Aerts JMFG, 542 Barohn RJ, 664 Brooks WS, 139 Cree B, 310, 327 Barrio LC, 749 Broome J, 855 Crimi M, 373 Ahlskog JE, 439 Ahsan RL, 634 Bart J, 176 Brune T, 148 Criscuolo C, 777 Aizenberg MR, 542 Bartfai T, 152, 609 Brusa L, 448, 777 Cruccu G, 824 Akatsu H, 585 Barthe N, 17 Bubber P, 695 Cudkowicz M, 104 Akkari PA, 42 Battista N, 777 Buchan AM, 848 Czaplinski A, 180 Beaudet AL, 557 Biihrer C, 50 Alafuzoff I, 82, 605 Alberg E, 600 Beaulieu, C, 188 Bunnage M, 298 Dail D, 813 Al-Gazali L, 513, 934 Behrens M, 152, 609 Bureau E, 34 Dal Forno G, 381 Allcock LM, 564 Bendszus M, 388 Burke D, 339 Dallapiccola B, 513, 934 Al-Tawari AA, 513, 934 Ben-Hur T, 741 Burleson T, 664 Dambrosia J, 526 Altmann DR, 622 Ben-Menachem O, 741 Burn DJ, 564 D’Andrea G, 925 Benner T, 679 Amarenco P, 472 Bussone G, 925 Dang X, 576 Benomar A, 567 Amato AA, 664 Butman JA, 526 Danta G, 904 Berendse HW, 157 Amorim SC, 730 Butters TD, 156 Dasgupta S, 795 Berg D, 535 Ampuero I, 634 Davidzon G, 921 Berkovic SF, 283, 465 Amrute S, 813 Berman KF, 453 Cadavid D, 813 D’Avino C, 304 Anchisi D, 216 Calle EE, 104 Davis D, 98 Bernardi G, 448, 777 Anderson NE, 293, 609 Berrih-Aknin S, 444 Campbell IL, 804 Davison J, 564 Andreasson K, 758 Camuzat A, 505 de Andrade M, 439 Berry-Kravis E, 144 Arai H, 832 Bertini E, 513, 934 Canelhas A, 444 De Coo RIFM, 589 Armstrong J, 549 Bezard E, 17 Cantarero S, 634 de la Torre JC, 783 Arnold A, 180 Bhavaraju NC, 258 Caplan LR, 469 de Lau LML, 928 Arts WFM, 589 Bioulac BH, 17 Carbon-Correll M, 596 De Michele G, 777 Asanuma K, 596 Birbaumer N, 466 Carpo M, 304 de Miguel M, 749 Asbury AK, 768 Bittigau P, 50 Carr JR, 131 De Simoni MG, 804 Ascherio A, 104, 713 Blackwell ML, 489 Carrier J, 277 de Visser M, 589 Asgeirsson H, 765 Bladen C, 745 Cascino GD, 610 De Vivo DC, 111 Aubert I, 17 Blaicher HP, 843 Cassaday MP, 226 de Yébenes JG, 634 Auburger G, 453 Blass JP, 695 Castelnau P, 738 Deacon R, 463 Auer-Grumbach M, 415 Bloch B, 17 Castori M, 513, 934 Décary A, 277 Auer-Grumbach P, 415 Bodamer OA, 557 Casucci G, 925 Del Bo R, 373 Augustinack JC, 489 Boeve BF, 480 Catani M, 8 Demchuk AM, 848 Austrian Peripheral Bolgert F, 434 Cavus I, 226 Demeret S, 434 Neuropathy Study Boltshauser E, 513, 934 Charon C, 567 den Heijer T, 779, 789 Group, 415 Boneschi FM, 373 Chatterjee A, 721 Denecke J, 148 Autere JM, 82, 605 B6nnemann CG, 148 Chinnery PF, 564 Deng H, 934 Ay H, 679 Booij J, 157 Chiras J, 434 Deseillilgny CP, 434 Azzedine H, 567 Borgna M, 180 Christensen E, 60 D’Hooghe M, 310 Borja MC, 156 Christian L, 649 Dib-Hajj SD, 785 Baas F, 589 Bostock H, 339 Christian LJ, 773 Dicaire MJ, 408 Bagnato F, 526 Bottiglieri T, 557 Chui HC, 896 Dickson DW, 480 Baier M, 50 Bouchard JP, 408 Gif L, 738 Dieterich M, 824 Bajenaru ML, 119 Bouhouche A, 567 Clarimon J, 765 DiGiorgio A, 738 Bakker SLM, 789 Bouslam N, 567 Clark CM, 721 DiMauro S, 921 Balash Y, 656 Bower JH, 439 Cleveland DW, 773 Dinse HR, 425, 609 Bali B, 464 Brady RO, 542 Cohen LG, 466 Dixon-Salazar T, 513, 934 Baloh RW, 131 Brais B, 408 Collins A, 310 Domazetovska A, 42 Balosso S, 804 Brandt T, 607 Comabella M, 210 Donaghy MJ, 293, 609 Bamberg M, 843 Breakefield XO, 34 Comi GC, 304 Dojfie S, 252 Bamonti F, 304 Brenner M, 310, 327 Comi GP, 373 Donohue JE, 381 January issue, 1-160; February issue, 161-306; March issue, 307-468; April issue, 469-612; May issue, 613-782; June issue, 783-936. © 2005 American Neurological Association 11A Published by Wiley-Liss, Inc., through Wiley Subscription Services Douglas JB, 293, 609 Foltynie T, 564 Griffin JW, 163, 768 Hopper JL, 465 Dovero S, 17 Fontan A, 634 Grivé E, 210 Horn T, 388 Doyu M, 236 Forster AF, 425, 609 Grodstein F, 713 Howell MJ, 349 Drobatz KJ, 355 Franceschi M, 216 Gross CE, 17 Huang C, 596 du Plessis DG, 855 Franzini A, 925 Gross DW, 188 Huang P, 197 Dubé C, 152, 609 Franzoni E, 327 Grossman M, 721 Hubbard JD, 462 Dubourg O, 553 Frasca S, 448 Gueorguieva R, 226 Hulihan M, 762 Duffy CJ, 305 Frei MG, 258 Guigoni C, 17 Hunter CB, 934 Duno M, 60 Frosch MP, 489 Guillevin R, 434 Husband D, 855 Dupuis L, 553 Frosk P, 591 Guimaraes P, 197 Duquette A, 408 Frost LM, 649 Gunning PW, 42 lannetti GD, 824 Durr A, 567 Fryns JP, 933 Guo Y, 934 Ibaraki M, 495 Diirr A, 505 Fuchs J, 535 ‘ Gurtman A, 576 Ikonomidou C, 50 Dwek RA, 156 Fuhr P, 180 Gutiérrez-Solana LG, 310, Illig T, 535 Dzietko M, 50 Fukuda T, 289 327 Irrthum A, 293, 609 Fukudome T, 289 Gutmann DH, 119 Isbister GK, 339 Earley C, 781 Fukui T, 604 Ishigaki S, 236 Echaniz-Laguna A, 553 Funayama M, 918 Habedank B, 128 Ishikawa A, 429 Edwards C, 596 Futatsubashi M, 168 Hainsworth AH, 448 Ivnik RJ, 480 Eggers SD, 581 Hakansson K, 17 Iwata N, 832 Eguchi K, 289 Gage FH, 649, 773 Halliday GM, 139 Eidelberg D, 596 Gagnon A, 848 Hans VH, 457 Jackson AC, 768 Ejstrup R, 60 Galati S, 448, 777 Hao S, 914 Jacob R, 226 Eliasziw M, 848 Galbiati S, 373 Hardeman EC, 42 Jacobs EJ, 104 Ellis WG, 896 Galimberti D, 373 Hardman J, 98 Jacobson PL, 468 Elm JJ, 197 Galimberti G, 373 Hardy J, 765 Jacobson S, 526 Engel AG, 269, 591 Gannau A, 738 Haroutunian V, 695 Jahn K, 607 Engelstad K, 111 Garbow JR, 119 Hartl G, 415 Jain S, 453 Engler M, 600 Garcia N, 396 Hartung HP, 415 Jakobs C, 327 Ericsson M, 664 Gasser T, 535 Harvey AS, 465 Jakobsson F, 765 Erne B, 180 Gattoni G, 448 Hasegawa K, 918 James AC, 904 Evans EW, 453 Gatz M, 27 Hashizume Y, 236 Jankovic J, 934 Evert BO, 457 Gee A, 855 Haskins ME, 355 Jen JC, 131 Eyre KED, 293, 609 Gee J, 721 Hata R, 585 Jeyakumar M, 156 GENIC Investigators, 472 Hatazawa J, 495 Jhung S, 111 Factor SA, 462 Genis D, 549 Haupt WF, 128 Jiang YM, 236 Fanjul S, 634 Gertz HJ, 780 HausdorfJfM , 656 Johnson AB, 310, 327 Farmer J, 721 Ghezzi S, 373 Hausler M, 600 Johnson J, 453 Farrer MJ, 439, 762 Gibson GE, 695 Hauw JJ, 553 Johnson N, 204 Fazio F, 216 Giftakis J, 258 Haylock B, 855 Johnson RT, 1 Fedele E, 448 Gil AM, 365 Heils A, 866 Johnston MV, 305 Felderhoff-Mueser U, 50 Giladi N, 656 Heiss WD, 128 Jokic N, 553 Fenoglio C, 373 Gilboa A, 741 Hemm S, 738 Jones A, 634 Fernandez-Mata I, 762 Gill SS, 298 Henderson AJ, 883 Jones DK, 8 Ferrarese C, 373 Glaser M, 607 Hendriks -H, 505 Jones M, 444 Ferraris S, 921 Glass JD, 749 Hendrikse NH, 176 Jones SJ, 622 Ferrie CD, 327 Gleeson JG, 513, 934 Hensel A, 780 Josephs KA, 480 Feuer A, 148 Glorioso JC, 914 Herberger S, 607 Joyce KA, 855 Fezza F, 777 Glynn SM, 581, 610 Herholz K, 128 ffytche DH, 8 Goebel A, 463 Hernandez DG, 453 Kachergus J, 762 Fildes D, 855 Goebel I, 303 Hernandez J, 634 Kaji R, 309 Filla A, 777 Goetz CG, 144, 197 Hernandez MR, 119 Kalfakis N, 520 Finazzi-Agro A, 777 Gold R, 444 Herrlinger U, 843 Kalnins RM, 283 Fink DJ, 914 Goldman JE, 310 Heywood P, 298 Kamino K, 585 Finnegan K, 687 Gomez CM, 349 Hickman SJ, 622 Kamp C, 197 Fisch G, 695 Gomez Garre P, 634 Higuchi M, 832 Kang JH, 713 Fischbeck KH, 687, 749 Gémez-Hernandez JM, 749 Hill MD, 848 Kanno T, 168 Fischer R, 415 Gonzalez de Aguilar JL, Hirano M, 634, 921 Kanz L, 843 Fischl BR, 489 553 Hjaltason H, 765 Karagiozis H, 381 Fisone G, 17 Gorry PR, 795 Hoenicka J, 634 Karnath HO, 843 Fitzek S, 824 Gosselin I, 408 Hofer A, 535 Kasoff WS, 226 Fitzgerald-Bocarsly P, 813 Goto M, 604 Hofman A, 779, 789, 928 Kaspar BK, 649, 773 Flaster E, 252 Greenberg SA, 664 Holden KR, 608 Katsuno M, 236 FlieSbach K, 457 Gregory G, 139 Holloway L, 252 Kauppinen T, 82, 605 Floel A, 466 Gresch M, 866 Holzbaur ELF, 687 Kawas CH, 381 Floeter MK, 687 Gribaa M, 513, 934 Hopf HC, 824 Kawashima N, 918 12A_ Author Index Kayserili H, 513, 934 Leight S, 721 Mathieu J, 408 Nagorsen U, 466 Keers SM, 564 Leineweber B, 50 Matsuba Y, 832 Naidu S, 310 Kennedy J, 848 Leist TP, 526 Matsui T, 832 Nakao Y, 289 Kennedy WR, 687 Leite MI, 444 Mattheisen M, 866 Namekawa M, 567 Kersaitis C, 139 Lenzen KP, 866 Matthijs G, 933 Napolitano S, 777 Kessler J, 128 Leone M, 925 Mattson MP, 758 Narayan K, 813 Ketelsen UP, 148, 303 Lepar G, 139 Mayer RF, 468 Nascimbene C, 67, 304 Khosravani H, 745 Lesnick TG, 439 Mazzone P, 448 Nelson J, 98 Kieburtz K, 197 Levin MC, 932 McArthur JC, 163 Nemoto M, 832 Kiernan MC, 339 Lewis SJ, 564 McCullough ML, 104 NET-PD Investigators, 197 Kim DE, 34 Leys D, 472 McEntagart ME, 293, 609 Neubauer BA, 866 Kim HY, 571 Lezirovitz K, 730 McFarland H, 526 Neuro-Oncology Working Kimonis V, 457 Li CY, 768 McGeer PL, 161 Group, German Cancer Kirschner J, 148 ki Ly 823 McGowan JC, 355 Society, 843 Kirshner HS, 781 Le: @ 17 Mclnerney-Leo A, 453 Neville DCA, 156 Kivipelto M, 780 Li R, 310; 327 McIntosh AM, 283 Newsom-Davis J, 444 Klebe S, 567 Lian XY, 642 McKhann GM, 615 Nicolas V, 425, 609 Kleines M, 600 Liang GSL, 749 McNabb-Baltar J, 408 Niks EH, 444 Kleinschnitz C, 388 Liang Y, 236 McNaught TP, 704 Niogi SN, 355 Klutzny U, 591 Lichtner P, 535 McRory JE, 745 Nishimura A, 730 Knecht S, 466 Lin CSY, 339 Meggouh F, 589 Nishizawa M, 429 Knopman DS, 480 Lincoln SJ, 439 Mehta SG, 457 Niwa J, 236 Kobayashi Y, 236 Lino AMM, 730 Meininger V, 553 Nodera H, 309 Koenig M, 513, 934 Liu D, 758 Meitinger T, 535 Noorbakhsh F, 883 Kok F, 730 Lo EH, 571 Menchise V, 777 North KN, 42 Komiyama M, 918 Lochmiiller H, 415, 591 Mercimek-Mahmutoglu S, Nos C, 210 Kondo I, 585 Loeffler JP, 553 560 Niirnberg P, 866 Kopitzki K, 136 Loisel L, 408 Messer J, 513, 934 Nussbaum RL, 453 Kops GJ, 773 Lombardi R, 180 Messing A, 310, 327 Nyggard T, 634 Koralnik IJ, 576 Lonser RR, 542 Mesulam MM, 5, 204 Korinthenberg R, 148 Lopez de Munain A, 365 Meucci G, 304 Obata F, 918 Koroshetz WJ, 679 Lopez GJ, 453 Meyer-Lindenberg A, 453 Obladen M, 50 Kortekaas R, 176 Lorenz S, 866 Micklem K, 444 O’Brien WE, 557 Korteweg T, 606 Ludlow CL, 687 Middaugh LD, 795 Offenbacher H, 415 Kosaka K, 585 Lueck CJ, 904 Miki T, 585 Ogusu T, 168 Koudstaal PJ, 779, 789, Miller DH, 622 Oh SJ, 687 928 Ma Y, 596 Miller TM, 773 Oh U, 526 Kowa H, 918 Maccarrone M, 777 Mintz M, 749 Ohayon J, 526 Kremer BPH, 505 Macedo-Souza LI, 730 Misselwitz B, 388 Ohta E, 918 Kretzschmar HA, 607 Maddess T, 904 Miszkiel KA, 622 Ohtake H, 429 Kril JJ, 139 Mahler L, 50 Mitchell LA, 283 Oldfield EH, 542 Krishnan C, 67, 304 Maier C, 425, 609 Miyashita A, 429 Olsen DB, 754 Krystal JH, 226 Mamah CE, 439 Mizukami H, 832 Omran H, 303 Kubisch C, 303 Mancini P, 777 Moeller JR, 596 Onodera O, 429 Kugler SL, 464 Mancuso M, 921 Mohebbi MR, 608 O’Reilly EJ, 104 Kiiker W, 843 Mann EA, 687 Montalban X, 210 Orlacchio A, 448 Kuroda Y, 932 Maraganore DM, 439 Mont’Alverne F, 434 @rngreen MC, 60, 754 Kuwano R, 429 Maramattom BV, 581 Montgomery EB Jr., 157 Ortiz N, 396 Kwok JB, 139 Marchand L, 408 Montplaisir J, 277 Osorio I, 258 Marcus R, 252 Moore P, 721 Ostertag CB, 136 Labreuche J, 472 Markesbery W, 98 Mora CA, 526 Ouchi Y, 168 Labuda D, 408 Markianos M, 520 Morbin M, 180 Ozawa K, 832 Laing NG, 42 Marquardt T, 148 Morcos Y, 932 Lambert C, 564 Marsh SE, 513, 934 Moresco RM, 216 Pachner AR, 813 Landau WM, 465 Marti I, 365 Morgello S, 576 Pack AM, 252 Lanuza MA, 396 Marti-Masso JF, 365 Morgenstern LB, 160 Paisan-Ruiz C, 365 Launer L, 98 Martinelli V, 304 Moritz R, 444 Paisan-Ruiz C, 453 Lauria G, 180 Maruyama M, 832 Morrell MJ, 252 Pal DK, 464 Lava NS, 462 Marx A, 444 Moser HW, 307 Palermo MT, 381 Le W, 934 Marx JJ, 824 Motomura M, 289 Palesch YY, 197 Lee G, 874 Masaki K, 98 Mueller JC, 535 Palumbo V, 848 Lee JS, 874 Mash DC, 605 Muhle H, 866 Pan JW, 92 Lee PH, 874 Massicotte-Marquez J, 277 Muller A, 553 Panas M, 520 Lee SM, 932 Mata M, 914 Mungas D, 896 Papapetropoulos S, 605 Lee VMY, 721 Matarrese M, 216 Muramatsu S, 832 Pardo CA, 67, 304 Leenders KL, 176 Mathieu A, 277 Murray GJ, 542 Pareyson D, 180 Author Index 13A Parisi JE, 480 Rahman M, 604 Schofield PR, 139 Sullivan A, 883 Park P, 664 Rahman N, 293, 609 Schoser BGH, 591 Sumner CJ, 687 Parker DB, 745 Raiteri M, 448 Schréder R, 457 Sun RP, 111 Parkkinen L, 82, 605 Ramos-Alvarez M, 768 Schiitz A, 388 Sunderam S, 258 Pascual JM, 111 Randall A, 252 Schwamm LH, 679 Suzuki A, 495 Passini MA, 355 Ravina B, 197 Schwartz M, 60 Suzuki M, 429 Patel NK, 298 Ravindran S, 466 Schwenkreis P, 425, 609 Sveinbjornsdottir S, 765 Pauls K, 457 Ravizza T, 804 Scott CB, 704 Svendsen CN, 298 Pavese N, 634 Raymond D, 596 Scott JN, 848 Swoboda KJ, 704 Pawitan Y, 27 Reddy A, 310, 327 Seale C, 252 Sztriha L, 513, 934 Payami H, 462 Reid SL, 293, 609 Seidl R, 560 Pedersen NL, 27 Reyna SP, 704 Seilhean D, 553 Taguchi K, 585 Pelati O, 216 Riedel-Heller SG, 780 Sekine Y, 168 Tai YF, 634 Pelayo R, 210 Rio J, 210 Selcen D, 269 Takahashi H, 429 Pender MP, 158 Ritter K, 600 Sellhaus B, 600 Takahashi K, 92 Pepicelli O, 448 Rizzo M, 936 Selnes OA, 615 Takaki Y, 832 Peppe A, 448 Robinson R, 327 Shah K, 34 Takeda M, 585 Peracchi M, 304 Robl T, 415 Shane E, 252 Takeuchi H, 236 Perani D, 216 Rocca WA, 439 Shannon K, 197 Tanaka F, 236 Perego C, 804 Roddier K, 408 Sheikh KA, 768 Tang Y, 34 Peretz C, 656 Rojo A, 634 Shepherd CE, 139 Tanji H, 832 Pérez-Tur J, 365, 634 Rolf CM, 310 Sherwin RS, 226 Tanner CM, 197 Perry A, 119 Roller MJ, 349 Shimosegawa E, 495 Tauer U, 866 PPeersrcyh onR H,J , 586044 RRoosss RG, W6,3 4 98 SShiierbaeirsth iJ R,H , 31208 9 Tawil R, 664 Petersen RC, 480 Rotteveel JJ, 560 Sifringer M, 50 Tegenthoff M, 425, 609 Petit D, 277 Rottnek M, 576 Simon JE, 848 Téllez N, 210 Petrovitch H, 98 Rovira A, 210 Simpson D, 576 Terao S, 236 Piao YS, 429 Roy J, 848 Singhal AB, 571 Terry EC, 795 Piccini P, 634 Ruberg M, 567 Singleton AB, 453, 765 Teubner A, 600 Pico F, 472 Rudolf G, 866 Sinke RJ, 505 Thal DR, 457 Pierantozzi M, 448, 777 Ruitenberg A, 789 Smit LME, 327 Thiel A, 128 Smith DA, 156 Thomas N, 327 Pinkus GS, 664 Ruseckaite R, 904 Smith GE, 480 Thoémke F, 824 Pinkus JL, 664 Ruyle SZ, 310 Smith T, 855 Thompson AJ, 622 Pirttila T, 82, 605 Snutch TP, 745 Thompson CK, 204 Pisani A, 777 Sabaté MM, 396 Sobue G, 236 Thorburn DR, 921 Pizzinelli S, 304 Sacca F, 777 Sohn CH, 848 Thun MJ, 104 Plaha P, 298 Sacchetti M, 60 Sommer C, 388 Tiangyou W, 564 Plant GT, 622 Saenz A, 365 Song YJC, 139 Tilley BC, 197 Platt FM, 156 Sahoo T, 557 Sonneville R, 434 Timmer J, 136 Pleger B, 425, 609 Saido TC, 832 Sorensen AG, 679 Tintoré M, 210 Plotnik M, 656 Salat DH, 489 Soreq H, 741 Toft M, 762 PPPPPPPPPPoooooooooollltrntlwwllltkasemeaaehenerarkkya ons n ss t KOY PC ,,,,MR,C K ,A MH,6 72,58, ,14 0608134 481 3 874 649 10 567 SSSSSSSSSSaaaaaaaaaalnnsptnnlnpat oetdooika roemeuNifssrotA iédt rn,c eooH osiSTu ,Ml, n,9 a M C3s7G2D8,8 DD3, 3,6,S 0 2H6 , 3, 3615 96061645,36 4 ,49 3 2973 4 SSSSSSSSSSptptttttttareaee-eeerfocnDnvipaltkzeacnhnit innehaineoiiron gA nns ri Je A n G,A D, ,,AG UD ,P1,,S4,, 48 7 C4 0643,858 4300 0264 8 52689 ,6, 8 576777 TTTTTTTTTooosooorournmomouyjieijsbaoizytayoss u-na u hkESo liAa,awJ mT rN,s9a, l,kPT13 e iJ,89y, 68 H6 23, J1422 KQ67 ,8,24 98578 231 Pradat PF, 553 Scaglia F, 557 Stock M, 463 Tsujihata M, 289 Pratico D, 721 Scalabrino G, 304 Stéckler-Ipsiroglu $, 557 Tsutsui S, 883 Prineas JW, 158 Scaravilli F, 444 Stoessl AJ, 161 Tyor WR, 795 Prior TW, 704 Scarlato M, 373 Stoeter P, 824 Puls I, 687 Scarpini E, 373 Stoffers D, 157 Uhl M, 843 Pyle A, 564 Schaffer AA, 453 Stoll G, 388 Uitdehaag BMJ, 606 Schaffner SF, 258 Strain KJ, 439 Uitterlinden AG, 928 Qian J, 462 Scheffer IE, 465 Strauch K, 866 Umapathi P, 649 Quinlan R, 310 Scheithauer S, 600 Stringer JL, 642 Urban PP, 824 Quinzii C, 921 Scheper GC, 560 Strobel P, 444 Scheren-Wiemers N, 180 Strobl-Wildemann G, 415 Vaalburg W, 176 Rabins P, 936 Scherer SS, 749 Strupp M, 607 Vadlamudi L, 465 Ragert P, 425, 609 Schlotter-Weigel B, 415 Sueoka E, 932 Valente EM, 513, 738, 934 Rahimi F, 139 Schmitz B, 866 Sueoka N, 932 Vallée JN, 434 14A Author Index van de Warrenburg BPC, Volpini V, 549 Wetzel RD, 465 Yahyaoui M, 567 505 Vortmeyer AO, 542, 687 White L, 896 Yamagata HD, 585 Van Deerlin V, 721 White LR, 98, 762 Yamamoto M, 236 van der Knaap MS, 310, Wagner C, 557 Wieacker P, 148 Yamamoto T, 585 327, 560 Wagner K, 415 Wiggins CJ, 489 Yamanaka K, 773 van der Kouwe AJW, 489 Walbridge S, 542 Wiggins GC, 489 Yamano Y, 526 van Eck-Smit BLF, 157 Wald LL, 489 Wijdicks EFM, 581 Van Esch H, 933 Walker C, 855 Wilkinson SB, 258 Yang H, 111 van Meurs JBJ, 928 Wallace KE, 687 Willcox N, 444 Yang K, 34 van Oostrom JCH, 176 Waltz S, 866 Willemsen ATM, 176 Yirmiya R, 741 van Schaik IN, 589 Waltz SE, 883 Williams IM, 156 Yoshida M, 236 van Swieten JC, 789 Wan J, 131 Winblad B, 780 Yoshihara T, 236 van Zuijlen MCA, 505 Wang D, 111 Windpassinger C, 415 Yoshikawa E, 168 Vandenberghe RR, 204 Warnke PC, 136, 855 Winhuisen L, 128 Yoshimura T, 289 Vandenbulcke M, 204 Warren K, 883 Wirdefeldt K, 27 Yu GY, 349 Vangel MG, 679 Wasner C, 148 Wolf H, 780 Vargasa DL, 67, 304 Watts GDJ, 457 Wolfe D, 914 Vassilopoulos D, 520 Waxman SG, 785 Wolfe JH, 355 Zaldivar RA, 581 Vayssiere N, 738 Wehnert M, 148 Wolters EC, 157 Zamponi GW, 745 Vazquez, 634 Weinberg D, 144 Woods CG, 513, 934 Zarow C, 896 Vendette M, 277 Weiner MW, 896 Wooten GF, 197 Zatz M, 730 Vermeulen G, 560 Weintraub S, 204 Work M, 721 Zhang Z, 642 Vezzani A, 152, 609, 804 Weisskopf MG, 104 Wride MC, 704 Zhong W, 585 Vidailhet M, 613 Weissleder R, 34 Wrogemann K, 591 Zhou L, 144 Vidal L, 634 Weller M, 843 Wu L, 758 Zimmerman AW, 67, 304 Vincent A, 289, 444, 463 Weller RO, 310 Wu O, 679 Vinters HV, 896 Wendelschafer-Crabb G, Wiillner U, 535 Zimprich A, 535 Virgilio R, 373 687 Wiithrich C, 576 Zingler VC, 607 Vissing J, 60, 754 Werhahn KJ, 466 Zonderman AB, 381 Vite CH, 355 Wessellingh SL, 795 Xie TD, 349 Zuffi M, 216 Vogt MR, 98 Wessig C, 388 Xie W, 934 Zwick EB, 415 Author Index 15A serum lipids and hippocampal volume: the link to Alzhei- Subject Index mer’s disease? (Wolf et al) 2005;57:780 (Letter) vascular endothelial growth factor gene variability is asso- ciated with increased risk for AD (Del Bo et al) 2005; 57:373 N-acetyl aspartate Alzheimer’s disease, early interdependence of N-acetyl aspartate and high-energy cerebrospinal fluid neprilysin is reduced in prodromal Alz- phosphates in healthy human brain (Pan and Taka- heimer’s disease (Maruyama et al) 2005;57:832 hashi) 2005;57:92 Alzheimer’s disease, presenilin-1 Acetylcholine receptors Pick bodies in a family with presenilin-1 Alzheimer’s dis- acetylcholine receptors loss and postsynaptic damage in ease (Halliday et al) 2005;57:139 MuSK antibody—positive myasthenia gravis (Shiraishi et Alzheimer’s disease, prodromal al) 2005;57:289 cerebrospinal fluid neprilysin is reduced in prodromal Alz- Acetylcholinesterase inhibitors heimer’s disease (Maruyama et al) 2005;57:832 acetylcholinesterase inhibitors reduce brain and blood Alzheimer’s disease, variant interleukin-18 production (Pollak et al) 2005;57:741 a mutant PSENI/ causes dementia with Lewy bodies and Acute intermittent porphyria variant Alzheimer’s disease (Ishikawa et al) 2005;57:429 Amyotrophic lateral sclerosis acute intermittent porphyria presenting as a diffuse en- gene expression profile of spinal motor neurons in spo- cephalopathy (Maramattom et al) 2005;57:581 radic amyotrophic lateral sclerosis (Jiang et al) 2005;57: Acute motor axonal neuropathy 236 puffer fish poisoning, Guillain-Barré syndrome and persis- Nogo expression in muscle correlates with amyotrophic tent sodium channels (Kaji and Nodera) 2005;57:309 lateral sclerosis severity (Jokic et al) 2005;57:553 (Editorial) synergy of insulin-like growth factor-1 and exercise in Adaptive cortical plasticity amyotrophic lateral sclerosis (Kaspar et al) 2005;57:649 adaptive cortical plasticity in higher visual areas after acute virus-delivered small RNA silencing sustains strength in optic neuritis (Toosy et al) 2005;57:622 amyotrophic lateral sclerosis (Miller et al) 2005;57:773 Aerobic training vitamin E intake and risk of amyotrophic lateral sclerosis aerobic training in patients with myotonic dystrophy type (Ascherio et al) 2005;57:104 1 (Orngreen et al) 2005;57:754 Animal models Aging effective gene therapy for an inherited CNS disease in a fruit and vegetable consumption and cognitive decline in large animal model (Vite et al) 2005;57:355 aging women (Kang et al) 2005;57:713 murine gammaherpesvirus-68 infection of mice: a new Alexander disease model for human cerebral Epstein-Barr virus infection Alexander disease: combined gene analysis and MRI clarify (Hiusler et al) 2005;57:600 pathogenesis and extend phenotype (Moser) 2005;57: natural history of neurofibromatosis 1—associated optic 307 (Editorial) nerve glioma in mice (Bajenaru et al) 2005;57:119 glial fibrillary acidic protein mutations in infantile, juve- protective effects of ginseng components in a rodent nile, and adult forms of Alexander disease (Li et al) model of neurodegeneration (Lian et al) 2005;57:642 2005;57:310 RON-regulated innate immunity is protective in an ani- unusual variants of Alexander’s disease (van der Knaap et mal model of multiple sclerosis (Tsutsui et al) 2005;57: al) 2005;57:327 883 Alpers syndrome tumor necrosis factor-a inhibits seizures in mice via p75 POLG mutations and Alpers syndrome (Mancuso et al) receptors (Balosso et al) 2005;57:804 2005;57:921 Annals of Neurology Alzheimer’s disease message from the editor (Johnson) 2005;57:1 AD lesions and infarcts in demented and non-demented Antibodies Japanese-American men (Petrovitch et al) 2005;57:98 acetylcholine receptors loss and postsynaptic damage in cerebrospinal fluid profile in frontotemporal dementia and MuSK antibody—positive myasthenia gravis (Shiraishi et Alzheimer’s disease (Grossman et al) 2005;57:721 al) 2005;57:289 depressive symptoms, sex, and risk for Alzheimer’s disease changes in the neuromuscular synapse induced by an an- (Dal Forno et al) 2005;57:381 tibody against gangliosides (Santafé et al) 2005;57:396 identification of hippocampus-related candidate genes for fewer thymic changes in MuSK antibody-positive than in Alzheimer’s disease (Taguchi et al) 2005;57:585 MuSK antibody—negative MG (Leite et al) 2005;57:444 is Alzheimer’s disease preceded by neurodegeneration or intravenous immunoglobulin response and evidence for cerebral hypoperfusion (de la Torre) 2005;57:783 (Ed- pathogenic antibodies in a case of complex regional itorial) pain syndrome 1 (Goebel et al) 2005;57:463 (Letter) mitochondrial abnormalities in Alzheimer brain: mecha- Antiepileptic drugs nistic implications (Bubber et al) 2005;57:695 bone mass and turnover in women with epilepsy on anti- neuron number in Alzheimer’s disease and ischemic vas- epileptic drug monotherapy (Pack et al) 2005;57:252 cular dementia (Zarow et al) 2005;57:896 Anti—myelin-associated glycoprotein neuropathy serum lipids and hippocampal volume: the link to Alzhei- IgM deposits on skin nerves in anti-myelin-associated gly- mer’s disease? (den Heijer et al) 2005;57:779 (Letter) coprotein neuropathy (Lombardi et al) 2005;57:180 January issue, 1-160; February issue, 161-306; March issue, 307—468; April issue, 469-612; May issue, 613-782; June issue, 783-936. 16A © 2005 American Neurological Association Published by Wiley-Liss, Inc., through Wiley Subscription Services Aphasia, primary progressive Blood paradoxical features of word finding difficulty in primary acetylcholinesterase inhibitors reduce brain and blood progressive aphasia (Vandenberghe et al) 2005;57:204 interleukin-18 production (Pollak et al) 2005;57:741 Apraxia, oculomotor Blood-brain barrier very late onset in ataxia oculomotor apraxia type | (Cris- blood-brain barrier dysfunction in parkinsonian midbrain cuolo et al) 2005;57:777 (Letter) in vivo (Kortekaas et al) 2005;57:176 Arterial dolichoectasia Bone mass intracranial arterial dolichoectasia and small-vessel disease bone mass and turnover in women with epilepsy on anti- in stroke patients (Pico et al) 2005;57:472 epileptic drug monotherapy (Pack et al) 2005;57:252 Arteriopathy, dilatative Bone mineral density dilatative arteriopathy (dolichoectasia): what is know and bone mass and turnover in women with epilepsy on anti- not known (Caplan) 2005;57:469 (Editorial) epileptic drug monotherapy (Pack et al) 2005;57:252 Ataxia Book reviews fragile X—associated tremor/ataxia syndrome in sisters re- Clinical Neurophysiology Volume I, Revised and Enlarged lated to X-inactivation (Berry-Kravis et al) 2005;57:144 Edition: EMG, Nerve Conduction, and Evoked Potentials, mutations in senataxin responsible for Quebec cluster of edited by Binnie et al (Mayer) 2005;57:468 ataxia with neuropathy (Duquette et al) 2005;57:408 Complex Worlds from Simpler Nervous Systems, edited by nonconsensus intronic mutations cause episodic ataxia Bradford (Rizzo) 2005;57:936 (Wan et al) 2005;57:131 Epilepsy and the Ketogenic Diet, edited by Stafstrom and should we screen for FMRI premutations in female sub- Rho (Johnston) 2005;57:305 jects presenting with ataxia? (Van Esch et al) 2005;57: Essays in Social Neuroscience, edited by Cacioppo and 933 (Letter) Berntson (Rabins) 2005;57:936 Ataxia, spinocerebellar Handbook of Stroke Prevention in Clinical Practice, edited age at onset variance analysis in spinocerebellar ataxias: a by Furie and Kelly (Morgenstern) 2005;57:160 study in a Dutch-French cohort (van de Warrenburg et Magnetic Resonance in Epilepsy: Neuroimaging Techniques, al) 2005;57:505 2nd ed, by Kuzniecky and Jackson (Glynn and Cascino) false-positive SCA8 gene test in a patient with pathologi- 2005;57:610 cally proven multiple system atrophy (Factor et al) The Neuropathology of Dementia, 2nd ed, edited by Esiri et 2005;57:462 (Letter) al (Crain) 2005;57:610 giant SCA8 alleles in nine children whose mother has two -alliative Care in Neurology, by Voltz et al (Jacobson) moderately large ones (Corral et al) 2005;57:549 2005;57:468 spinocerebellar ataxia type 26 maps to chromosome Restless Legs Syndrome, edited by Chaudhuri et al (Earley) 19p13.3 adjacent to SCAG (Yu et al) 2005;57:349 2005;57:781 Ataxia with oculomotor apraxia type I Review of Aphasia and Related Neurogenic Language Disor- very late onset in ataxia oculomotor apraxia type | (Cris- ders, 3rd ed, edited by LaPointe (Kirshner) 2005;57:781 cuolo et al) 2005;57:777 (Letter) Atrophy, multiple system Textbook of Diabetic Neuropathy, edited by Gries et al (Cornblath) 2005;57:160 false-positive SCA8 gene test in a patient with pathologi- cally proven multiple systém atrophy (Factor et al) Vision and Seeing: It’s Not What You Think, by Pylyshyn 2005;57:462 (Letter) (Duffy) 2005;57:305 Autism Brain neuroglial activation and neuroinflammation in the brain acetylcholinesterase inhibitors reduce brain and blood of patients with autism (Vargas et al) 2005;57:67, interleukin-18 production (Pollak et al) 2005;57:741 2005;57:304 (Correction) AD lesions and infarcts in demented and non-demented Autoimmunity Japanese-American men (Petrovitch et al) 2005;57:98 autoimmunity to heterogeneous nuclear ribonucleopro- interdependence of N-acetyl aspartate and high-energy teins in neurological disease (Levin et al) 2005;57:932 phosphates in healthy human brain (Pan and Taka- (Letter) hashi) 2005;57:92 autoimmunity to heterogeneous nuclear ribonucleoproteins mitochondrial abnormalities in Alzheimer brain: mecha- in neurological disease (Sueoka et al) 2005;57:932 (Reply) nistic implications (Bubber et al) 2005;57:695 Axonal Guillain-Barré syndrome neuroglial activation and neuroinflammation in the brain overlap of pathology in paralytic rabies and axonal of patients with autism (Vargas et al) 2005;57:67, Guillain-Barré syndrome (Sheikh et al) 2005;57:768 2005;57:304 (Correction) Brain development caspase-1—processed interleukins in hyperoxia-induced cell Basque families death in the developing brain (Felderhoff-Mueser et al) familial Parkinson’s disease: clinical and genetic analysis 2005;57:50 of four Basque families (Paisan-Ruiz et al) 2005;57: Brain infarction 365 transient ischemic attack with infarction: a unique syn- Berardinelli-Seip congenital lipodystrophy gene 2 drome? (Ay et al) 2005;57:679 phenotypes of the N88S Berardinelli-Seip congenital lipo- Brain infarction, acute dystrophy 2 mutation (Auer-Grumbach et al) 2005;57: metabolic penumbra of acute brain infarction: a correlation 415 with infarct growth (Shimosegawa et al) 2005;57:495 Biopsy, skin Brain tumors another tool for the neurologist’s toolbox (McArthur and essential language function of the right hemisphere in Griffin) 2005;57:163 (Editorial) brain tumor patients (Thiel et al) 2005;57:128 Subject Index 17A Brainstem Cerebrospinal fluid somatotopic organization of the corticospinal tract in the cerebrospinal fluid neprilysin is reduced in prodromal Alz- human brainstem: a MRI-based mapping analysis heimer’s disease (Maruyama et al) 2005;57:832 (Marx et al) 2005;57:824 cerebrospinal fluid profile in frontotemporal dementia and Bulbar muscular atrophy Alzheimer’s disease (Grossman et al) 2005;57:721 distal spinal and bulbar muscular atrophy caused by dyn- high endogenous cannabinoid levels in the cerebrospinal actin mutation (Puls et al) 2005;57:687 fluid of untreated Parkinson’s disease patients (Pisani et N-Butyldeoxynojirimycin al) 2005;57:777 (Letter) NSAIDs increase survival in the Sandhoff disease mouse: high tumor necrosis factor-a levels in cerebrospinal fluid synergy with N-butyldeoxynojirimycin (Jeyakumar et of cobalamin-deficient patients (Scalabrino et al) 2005; al) 2005;57:156 (Correction) 57:304 (Correction) Bypass surgery Cerebrovascular lesions neurocognitive complications after coronary artery bypass AD lesions and infarcts in demented and non-demented surgery (Selnes and McKhann) 2005;57:615 Japanese-American men (Petrovitch et al) 2005;57:98 Charcot-Marie-Tooth disease Calcium channel mutations early onset neuropathy in a compound form of Charcot- effects of Ca,3.2 channel mutations linked to idiopathic Marie-Tooth disease (Meggouh et al) 2005;57:589 generalized epilepsy (Khosravani et al) 2005;57:745 Chemokine ligand CXCL13 Cannabinoids the nervous system as ectopic germinal center: CXCL13 high endogenous cannabinoid levels in the cerebrospinal and IgG in Lyme neuroborreliosis (Narayan et al) 2005; fluid of untreated Parkinson’s disease patients (Pisani et 57:813 al) 2005;57:777 (Letter) Chromosome 19p13.3 Capillaries spinocerebellar ataxia type 26 maps to chromosome capillary physiology and drug delivery in central nervous 19p13.3 adjacent to SCA6 (Yu et al) 2005;57:349 system lymphomas (Warnke et al) 2005;57:136 Chromosome 1q31.1 Carnitine palmitoyltransferase 2 gene (CPT2) genetic linkage of autosomal dominant progressive su- fuel utilization in subjects with carnitine palmitoyltrans- pranuclear palsy to 1q31.1 (Ros et al) 2005;57:634 ferase 2 gene mutations (Orngreen et al) 2005;57:60 Chromosome 11q13 Caspase-1 spastic paraplegia, optic atrophy, and neuropathy is linked to caspase-1—processed interleukins in hyperoxia-induced cell chromosome 11q13 (Macedo-Souza et al) 2005;57:730 death in the developing brain (Felderhoff-Mueser et al) Chromosome 12q23-q24 2005;57:50 confirmation of a hereditary motor and sensory neuropa- Caveolin-3 gene (CAV3) thy IIC locus at chromosome 12q23-q24 (McEntagart autosomal recessive rippling muscle disease with homozy- et al) 2005;57:293, 2005;57:609 (Correction) gous CAV3 mutations (Kubisch et al) 2005;57:303 Cobalamin deficiency (Letter) high tumor necrosis factor-a levels in cerebrospinal fluid Cell death of cobalamin-deficient patients (Scalabrino et al) 2005; caspase-1—processed interleukins in hyperoxia-induced cell 57:304 (Correction) death in the developing brain (Felderhoff-Mueser et al) Cognitive decline 2005;57:50 fruit and vegetable consumption and cognitive decline in Central nervous system lymphoma aging women (Kang et al) 2005;57:713 capillary physiology and drug delivery in central nervous Combined methylmalonic aciduria and homocystinuria system lymphomas (Warnke et al) 2005;57:136 creatine metabolism in combined methylmalonic aciduria NOA-03 multicenter trial of high-dose methotrexate ther- and homocystinuria (Bodamer et al) 2005;57:557 apy in primary central nervous system lymphoma: final Complex regional pain syndrome report (Herrlinger et al) 2005;57:843 sensorimotor returning in complex regional pain syn- Cerebral cortex drome parallels pain reduction (Pleger et al) 2005;57: imaging connectivity in the human cerebral cortex: the 425, 2005;57:669 (Correction) next frontier? (Mesulam) 2005;57:5 (Editorial) Complex regional pain syndrome 1 Cerebral Epstein-Barr virus infection intravenous immunoglobulin response and evidence for murine gammaherpesvirus-68 infection of mice: a new pathogenic antibodies in a case of complex regional model for human cerebral Epstein-Barr virus infection pain syndrome 1 (Goebel et al) 2005;57:463 (Letter) (Hausler et al) 2005;57:600 Connectivity Cerebral fat embolism imaging connectivity in the human cerebral cortex: the cerebral fat embolism: usefulness of magnetic resonance next frontier? (Mesulam) 2005;57:5 (Editorial) spectroscopy (Guillevin et al) 2005;57:434 Connexin32 Cerebral hypoperfusion severe neuropathy with leaky connexin32 hemichannels cerebral hypoperfusion and clinical onset of dementia: the (Liang et al) 2005;57:749 Rotterdam study (Ruitenberg et al) 2005;57:789 Convection perfusion is Alzheimer’s disease preceded by neurodegeneration or convection perfusion of glucocerebrosidase for neurono- cerebral hypoperfusion (de la Torre) 2005;57:783 (Ed- pathic Gaucher’s disease (Lonser et al) 2005;57:542 itorial) Coronary artery bypass surgery Cerebral ischemia, focal neurocognitive complications after coronary artery bypass neuroprotection by the PGE, EP2 receptor in permanent surgery (Selnes and McKhann) 2005;57:615 focal cerebral ischemia (Liu et al) 2005;57:758 Cortex normobaric hyperoxia extends the reperfusion window in extracellular metabolites in the cortex and hippocampus of focal cerebral ischemia (Kim et al) 2005;57:571 epileptic patients (Cavus et al) 2005;57:226 18A Subject Index Cortical plasticity intracranial arterial dolichoectasia and small-vessel disease adaptive cortical plasticity in higher visual areas after acute in stroke patients (Pico et al) 2005;57:472 optic neuritis (Toosy et al) 2005;57:622 Dopa-responsive dystonia Corticospinal tract the metabolic pathology of dopa-responsive dystonia somatotopic organization of the corticospinal tract in the (Asanuma et al) 2005;57:596 human brainstem: a MRI-based mapping analysis Dopamine (Marx et al) 2005;57:824 microglial activation and dopamine terminal loss in early Creatine Parkinson’s disease (Ouchi et al) 2005;57:168 creatine metabolism in combined methylmalonic aciduria Dopamine receptors and homocystinuria (Bodamer et al) 2005;57:557 increased D, dopamine receptor signaling in levodopa- Creutzfeldt-Jakob disease induced dyskinesia (Aubert et al) 2005;57:17 upbeat nystagmus as the initial clinical sign of Creutzfeldt- Drug delivery Jakob disease (Zingler et al) 2005;57:607 (Letter) capillary physiology and drug delivery in central nervous Cyclic guanosine monophosphate system lymphomas (Warnke et al) 2005;57:136 subthalamic stimulation activates internal pallidus: evi- convection perfusion of glucocerebrosidase for neurono- dence from cGMP microdialysis in PD patients (Stefani pathic Gaucher’s disease (Lonser et al) 2005;57:542 et al) 2005;57:448 Drug resistance deep brain stimulation to relieve severe drug-resistant Deep brain stimulation SUNCT (Leone et al) 2005;57:925 deep brain stimulation for dystonia: make the lame walk Drugs, nonsteroidal antiinflammater (Vidailhet and Pollak) 2005;57:613 (Editorial) NSAIDs increase survival in the Sandhoff disease mouse: deep brain stimulation to relieve severe drug-resistant synergy with N-butyldeoxynojirimycin (Jeyakumar et SUNCT (Leone et al) 2005;57:925 al) 2005;57:156 (Correction) pallidal stimulation improves pantothenate kinase—associ- Dynactin ated neurodegeneration (Castelnau et al) 2005;57:738 distal spinal and bulbar muscular atrophy caused by dyn- subthalamic stimulation activates internal pallidus: evi- actin mutation (Puls et al) 2005;57:687 dence from cGMP microdialysis in PD patients (Stefani Dyskinesia et al) 2005;57:448 increased D, dopamine receptor signaling in levodopa- Dementia induced dyskinesia (Aubert et al) 2005;57:17 AD lesions and infarcts in demented and non-demented Dystonia Japanese-American men (Petrovitch et al) 2005;57:98 deep brain stimulation for dystonia: make the lame walk cerebral nypoperfusion and clinical onset of dementia: the (Vidailhet and Pollak) 2005;57:613 (Editorial) Rotterdam study (Ruitenberg et al) 2005;57:789 Dystonia, dopa-responsive plasma testosterone in male patients with Huntington’s the metabolic pathology of dopa-responsive dystonia disease: relations to severity of illness and dementia (Asanuma et al) 2005;57:596 (Markianos et al) 2005;57:520 Dystonia, idiopathic a-synuclein pathology does not predict extrapyramidal torsin A haplotype predisposes to idiopathic dystonia (Cla- symptoms or dementia (Parkkinen et al) 2095;57:82 rimon et al) 2005;57:765 Dementia, frontotemporal cerebrospinal fluid profile in frontotemporal dementia and Early onset neuropathy Alzheimer’s disease (Grossman et al) 2005;57:721 early onset neuropathy in a compound form of Charcot- mutant valosin-containing protein causes a novel type of Marie-Tooth disease (Meggouh et al) 2005;57:589 frontotemporal dementia (Schréder et al) 2005;57:457 Editorials Dementia, vascular Alexander disease: combined gene analysis and MRI clarify correlates of hippocampal in Alzheimer’s disease and isch- pathogenesis and extend phenotype (Moser) 2005;57: emic vascular dementia (Zarow et al) 2005;57:896 307 Dementia with Lewy bodies another tool for the neurologist’s toolbox (McArthur and a mutant PSENI causes dementia with Lewy bodies and Griffin) 2005;57:163 variant Alzheimer’s disease (Ishikawa et al) 2005;57:429 deep brain stimulation for dystonia: make the lame walk Depressive symptoms (Vidailhet and Pollak) 2005;57:613 depressive symptoms, sex, and risk for Alzheimer’s disease dilatative arteriopathy (dolichoectasia): what is know and (Dal Forno et al) 2005;57:381 not known (Caplan) 2005;57:469 Dermatomyositis hot spots: can positron emission tomography offer insights interferon-a/B—mediated innate immune mechanisms in into the pathogenesis of PD? (Stoess! and McGeer) dermatomyositis (Greenberg et al) 2005;57:664 2005;57:160 Diffuse encephalopathy imaging connectivity in the human cerebral cortex: the acute intermittent porphyria presenting as a diffuse en- next frontier? (Mesulam) 2005;57:5 cephalopathy (Maramattom et al) 2005;57:581 is Alzheimer’s disease preceded by neurodegeneration or Dilatative arteriopathy cerebral hypoperfusion (de la Torre) 2005;57:783 dilatative arteriopathy (dolichoectasia): what is know and puffer fish poisoning, Guillain-Barré syndrome and persis- not known (Caplan) 2005;57:469 (Editorial) tent sodium channels (Kaji and Nodera) 2005;57:309 Distal spinal and bulbar muscular atrophy Electrical stimulation distal spinal and bulbar muscular atrophy caused by dyn- automated seizure abatement in humans using electrical actin mutation (Puls et al) 2005;57:687 stimulation (Osorio et al) 2005;57:258 Dolichoectasia Encephalitis dilatative arteriopathy (dolichoectasia): what is know and highly active antiretroviral therapy and human immuno- not known (Caplan) 2005;57:469 (Editorial) deficiency virus encephalitis (Cook et al) 2005;57:795 Subject Index 19A Encephalopathy, diffuse Freezing of gait acute intermittent porphyria presenting as a diffuse en- is freezing of gait in Parkinson’s disease related to asym- cephalopathy (Maramattom et al) 2005;57:581 metric motor function (Plotnik et al) 2005;57:656 Entorhinal layer II Fright detection of entorhinal layer II using Tesla magnetic res- fright is a provoking factor in vanishing white matter dis- onance imaging (Augustinack et al) 2005;57:489 ease (Vermeulen et al) 2005;57:560 Epidermal growth factor Frontotemporal dementia high tumor necrosis factor-a levels in cerebrospinal fluid cerebrospinal fluid profile in frontotemporal dementia and of cobalamin-deficient patients (Scalabrino et al) 2005; Alzheimer’s disease (Grossman et al) 2005;57:721 57:304 (Correction) mutant valosin-containing protein causes a novel type of Epilepsy frontotemporal dementia (Schréder et al) 2005;57:457 bone mass and turnover in women with epilepsy on anti- Frontotemporal lobe degeneration epileptic drug monotherapy (Pack et al) 2005;57:252 antemortem diagnosis of frontotemporal lobar degenera- extracellular metabolites in the cortex and hippocampus of tion (Knopman et al) 2005;57:480 epileptic patients (Cavus et al) 2005;57:226 glucose metabolism and serotonin receptors in the fronto- Epilepsy, idiopathic generalized temporal lobe degeneration (Franceschi et al) 2005;57: effects of Ca,3.2 channel mutations linked to idiopathic 216 generalized epilepsy (Khosravani et al) 2005;57:745 Fruit and vegetable consumption genetic dissection of photosensitivity and its relation to id- fruit and vegetable consumption and cognitive decline in iopathic generalized epilepsy (Tauer et al) 2005;57:866 aging women (Kang et al) 2005;57:713 Epilepsy, rolandic Futility studies genetic influence on rolandic epilepsy (Bali et al) 2005;57: a responsive outcome for Parkinson’s disease neuroprotec- 464 (Letter) tion futility studies (Elm et al) 2005;57:197 genetic influence on rolandic epilepsy (Vadlamudi et al) 2005;57:465 (Reply) Gadofluorine M Epilepsy, temporal lobe assessment of nerve degeneration by gadofluorine M-—en- bilateral limbic diffusion abnormalities in unilateral tem- hanced magnetic resonance imaging (Bendszus et al) poral lobe epilepsy (Concha et al) 2005;57:188 2005;57:388 Episodic ataxia Gait, freezing of nonconsensus intronic mutations cause episodic ataxia is freezing of gait in Parkinson’s disease related to asym- (Wan et al) 2005;57:131 metric motor function (Plotnik et al) 2005;57:656 Epstein-Barr virus infection Gangliosides murine gammaherpesvirus-68 infection of mice: a new changes in the neuromuscular synapse induced by an an- model for human cerebral Epstein-Barr virus infection tibody against gangliosides (Santafé et al) 2005;57:396 (Hausler et al) 2005;57:600 Gaucher’s disease Erythromelalgia convection perfusion of glucocerebrosidase for neurono- erythromelalgia: a hereditary pain syndrome enters the pathic Gaucher’s disease (Lonser et al) 2005;57:542 molecular era (Waxman and Dib-Hajj) 2005;57:785 Gene expression profiles Exercise gene expression profile of spinal motor neurons in spo- synergy of insulin-like growth factor-1 and exercise in radic amyotrophic lateral sclerosis (Jiang et al) 2005;57: amyotrophic lateral sclerosis (Kaspar et al) 2005;57:649 236 Extracellular metabolites Gene therapy extracellular metabolites in the cortex and hippocampus of effective gene therapy for an inherited CNS disease in a epileptic patients (Cavus et al) 2005;57:226 large animal model (Vite et al) 2005;57:355 Extrapyramidal symptoms virus-delivered small RNA silencing sustains strength in a-synuclein pathology does not predict extrapyramidal symptoms or dementia (Parkkinen et al) 2005;57:82 amyotrophic lateral sclerosis (Miller et al) 2005;57:773 Gene transfer Familial Parkinson’s disease gene transfer of glutamic acid decarboxylase reduces neu- familial Parkinson’s disease: clinical and genetic analysis of ropathic pain (Hao et al) 2005;57:914 four Basque families (Paisan-Ruiz et al) 2005;57:365 Genes Fat embolism identification of hippocampus-related candidate genes for cerebral fat embolism: usefulness of magnetic resonance Alzheimer’s disease (Taguchi et al) 2005;57:585 spectroscopy (Guillevin et al) 2005;57:434 Genetics Febrile seizures distinguishing the four genetic causes of Jouberts syndro- interleukin-18 and febrile seizures: from bench to bedside me-related disorders (Valente et al) 2005;57:513 (Mohebbi and Holden) 2005;57:608 (Letter) familial Parkinson’s disease: clinical and genetic analysis of interleukin-18 contributes to the generation of experimen- four Basque families (Paisan-Ruiz et al) 2005;57:365 tal febrile seizures (Dubé et al) 2005;57:152, 2005;57: genetic and clinical identification of Parkinson’s disease 609 (Correction) patients with LRRK2 G2019S mutation (Deng et al) FMRI premutation screening 2005;57:934 (Letter) should we screen for FMRI premutations in female sub- genetic dissection of photosensitivity and its relation to id- jects presenting with ataxia? (Van Esch et al) 2005;57: iopathic generalized epilepsy (Tauer et al) 2005;57:866 933 (Letter) genetic influence on rolandic epilepsy (Bali et al) 2005;57: Fragile X-associated tremor/ataxia syndrome 464 (Letter) fragile X—associated tremor/ataxia syndrome in sisters re- genetic influence on rolandic epilepsy (Vadlamudi et al) lated to X-inactivation (Berry-Kravis et al) 2005;57:144 2005;57:465 (Reply) 20A Subject Index

ebook img

Annals of Neurology 2005: Vol 57 Index PDF

2005·5.3 MB·English
by  
#periodicals #sim_microfilm #pub_annals-of-neurology
Save to my drive
Quick download
Download
Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Annals of Neurology 2005: Vol 57 Index

INDEXES TO VOLUME 57 Banchs I, 549 Bresolin N, 304, 373 Concha, L, 188 Author Banfi S, 777 Bressman SB, 596 Cook JE, 795 Bang OY, 874 Breteler MMB, 779, 789, Cooper ST, 42 Index Banwell B, 310, 327 928 Corbett MA, 42 Baram TZ, 152, 609 Breyer R, 758 Cornblath DR, 160 Barber PA, 848 Brice A, 505, 567 Corral J, 549 Barbot C, 513, 934 Briemberg HR, 664 Coslett HB, 721 Barker GJ, 622 Broggi G, 925 Coubes P, 738 Aasly JO, 762 Barker R, 564 Broich P, 457 Coutts SB, 848 Abbott RD, 98 Barkhof F, 327, 606 Bromberg MB, 704 Cox H, 310 Abi-Saab WM, 226 Barnett MH, 158 Brooks DJ, 634 Crain BJ, 610 Adachi H, 236 Aerts JMFG, 542 Barohn RJ, 664 Brooks WS, 139 Cree B, 310, 327 Barrio LC, 749 Broome J, 855 Crimi M, 373 Ahlskog JE, 439 Ahsan RL, 634 Bart J, 176 Brune T, 148 Criscuolo C, 777 Aizenberg MR, 542 Bartfai T, 152, 609 Brusa L, 448, 777 Cruccu G, 824 Akatsu H, 585 Barthe N, 17 Bubber P, 695 Cudkowicz M, 104 Akkari PA, 42 Battista N, 777 Buchan AM, 848 Czaplinski A, 180 Beaudet AL, 557 Biihrer C, 50 Alafuzoff I, 82, 605 Alberg E, 600 Beaulieu, C, 188 Bunnage M, 298 Dail D, 813 Al-Gazali L, 513, 934 Behrens M, 152, 609 Bureau E, 34 Dal Forno G, 381 Allcock LM, 564 Bendszus M, 388 Burke D, 339 Dallapiccola B, 513, 934 Al-Tawari AA, 513, 934 Ben-Hur T, 741 Burleson T, 664 Dambrosia J, 526 Altmann DR, 622 Ben-Menachem O, 741 Burn DJ, 564 D’Andrea G, 925 Benner T, 679 Amarenco P, 472 Bussone G, 925 Dang X, 576 Benomar A, 567 Amato AA, 664 Butman JA, 526 Danta G, 904 Berendse HW, 157 Amorim SC, 730 Butters TD, 156 Dasgupta S, 795 Berg D, 535 Ampuero I, 634 Davidzon G, 921 Berkovic SF, 283, 465 Amrute S, 813 Berman KF, 453 Cadavid D, 813 D’Avino C, 304 Anchisi D, 216 Calle EE, 104 Davis D, 98 Bernardi G, 448, 777 Anderson NE, 293, 609 Berrih-Aknin S, 444 Campbell IL, 804 Davison J, 564 Andreasson K, 758 Camuzat A, 505 de Andrade M, 439 Berry-Kravis E, 144 Arai H, 832 Bertini E, 513, 934 Canelhas A, 444 De Coo RIFM, 589 Armstrong J, 549 Bezard E, 17 Cantarero S, 634 de la Torre JC, 783 Arnold A, 180 Bhavaraju NC, 258 Caplan LR, 469 de Lau LML, 928 Arts WFM, 589 Bioulac BH, 17 Carbon-Correll M, 596 De Michele G, 777 Asanuma K, 596 Birbaumer N, 466 Carpo M, 304 de Miguel M, 749 Asbury AK, 768 Bittigau P, 50 Carr JR, 131 De Simoni MG, 804 Ascherio A, 104, 713 Blackwell ML, 489 Carrier J, 277 de Visser M, 589 Asgeirsson H, 765 Bladen C, 745 Cascino GD, 610 De Vivo DC, 111 Aubert I, 17 Blaicher HP, 843 Cassaday MP, 226 de Yébenes JG, 634 Auburger G, 453 Blass JP, 695 Castelnau P, 738 Deacon R, 463 Auer-Grumbach M, 415 Bloch B, 17 Castori M, 513, 934 Décary A, 277 Auer-Grumbach P, 415 Bodamer OA, 557 Casucci G, 925 Del Bo R, 373 Augustinack JC, 489 Boeve BF, 480 Catani M, 8 Demchuk AM, 848 Austrian Peripheral Bolgert F, 434 Cavus I, 226 Demeret S, 434 Neuropathy Study Boltshauser E, 513, 934 Charon C, 567 den Heijer T, 779, 789 Group, 415 Boneschi FM, 373 Chatterjee A, 721 Denecke J, 148 Autere JM, 82, 605 B6nnemann CG, 148 Chinnery PF, 564 Deng H, 934 Ay H, 679 Booij J, 157 Chiras J, 434 Deseillilgny CP, 434 Azzedine H, 567 Borgna M, 180 Christensen E, 60 D’Hooghe M, 310 Borja MC, 156 Christian L, 649 Dib-Hajj SD, 785 Baas F, 589 Bostock H, 339 Christian LJ, 773 Dicaire MJ, 408 Bagnato F, 526 Bottiglieri T, 557 Chui HC, 896 Dickson DW, 480 Baier M, 50 Bouchard JP, 408 Gif L, 738 Dieterich M, 824 Bajenaru ML, 119 Bouhouche A, 567 Clarimon J, 765 DiGiorgio A, 738 Bakker SLM, 789 Bouslam N, 567 Clark CM, 721 DiMauro S, 921 Balash Y, 656 Bower JH, 439 Cleveland DW, 773 Dinse HR, 425, 609 Bali B, 464 Brady RO, 542 Cohen LG, 466 Dixon-Salazar T, 513, 934 Baloh RW, 131 Brais B, 408 Collins A, 310 Domazetovska A, 42 Balosso S, 804 Brandt T, 607 Comabella M, 210 Donaghy MJ, 293, 609 Bamberg M, 843 Breakefield XO, 34 Comi GC, 304 Dojfie S, 252 Bamonti F, 304 Brenner M, 310, 327 Comi GP, 373 Donohue JE, 381 January issue, 1-160; February issue, 161-306; March issue, 307-468; April issue, 469-612; May issue, 613-782; June issue, 783-936. © 2005 American Neurological Association 11A Published by Wiley-Liss, Inc., through Wiley Subscription Services Douglas JB, 293, 609 Foltynie T, 564 Griffin JW, 163, 768 Hopper JL, 465 Dovero S, 17 Fontan A, 634 Grivé E, 210 Horn T, 388 Doyu M, 236 Forster AF, 425, 609 Grodstein F, 713 Howell MJ, 349 Drobatz KJ, 355 Franceschi M, 216 Gross CE, 17 Huang C, 596 du Plessis DG, 855 Franzini A, 925 Gross DW, 188 Huang P, 197 Dubé C, 152, 609 Franzoni E, 327 Grossman M, 721 Hubbard JD, 462 Dubourg O, 553 Frasca S, 448 Gueorguieva R, 226 Hulihan M, 762 Duffy CJ, 305 Frei MG, 258 Guigoni C, 17 Hunter CB, 934 Duno M, 60 Frosch MP, 489 Guillevin R, 434 Husband D, 855 Dupuis L, 553 Frosk P, 591 Guimaraes P, 197 Duquette A, 408 Frost LM, 649 Gunning PW, 42 lannetti GD, 824 Durr A, 567 Fryns JP, 933 Guo Y, 934 Ibaraki M, 495 Diirr A, 505 Fuchs J, 535 ‘ Gurtman A, 576 Ikonomidou C, 50 Dwek RA, 156 Fuhr P, 180 Gutiérrez-Solana LG, 310, Illig T, 535 Dzietko M, 50 Fukuda T, 289 327 Irrthum A, 293, 609 Fukudome T, 289 Gutmann DH, 119 Isbister GK, 339 Earley C, 781 Fukui T, 604 Ishigaki S, 236 Echaniz-Laguna A, 553 Funayama M, 918 Habedank B, 128 Ishikawa A, 429 Edwards C, 596 Futatsubashi M, 168 Hainsworth AH, 448 Ivnik RJ, 480 Eggers SD, 581 Hakansson K, 17 Iwata N, 832 Eguchi K, 289 Gage FH, 649, 773 Halliday GM, 139 Eidelberg D, 596 Gagnon A, 848 Hans VH, 457 Jackson AC, 768 Ejstrup R, 60 Galati S, 448, 777 Hao S, 914 Jacob R, 226 Eliasziw M, 848 Galbiati S, 373 Hardeman EC, 42 Jacobs EJ, 104 Ellis WG, 896 Galimberti D, 373 Hardman J, 98 Jacobson PL, 468 Elm JJ, 197 Galimberti G, 373 Hardy J, 765 Jacobson S, 526 Engel AG, 269, 591 Gannau A, 738 Haroutunian V, 695 Jahn K, 607 Engelstad K, 111 Garbow JR, 119 Hartl G, 415 Jain S, 453 Engler M, 600 Garcia N, 396 Hartung HP, 415 Jakobs C, 327 Ericsson M, 664 Gasser T, 535 Harvey AS, 465 Jakobsson F, 765 Erne B, 180 Gattoni G, 448 Hasegawa K, 918 James AC, 904 Evans EW, 453 Gatz M, 27 Hashizume Y, 236 Jankovic J, 934 Evert BO, 457 Gee A, 855 Haskins ME, 355 Jen JC, 131 Eyre KED, 293, 609 Gee J, 721 Hata R, 585 Jeyakumar M, 156 GENIC Investigators, 472 Hatazawa J, 495 Jhung S, 111 Factor SA, 462 Genis D, 549 Haupt WF, 128 Jiang YM, 236 Fanjul S, 634 Gertz HJ, 780 HausdorfJfM , 656 Johnson AB, 310, 327 Farmer J, 721 Ghezzi S, 373 Hausler M, 600 Johnson J, 453 Farrer MJ, 439, 762 Gibson GE, 695 Hauw JJ, 553 Johnson N, 204 Fazio F, 216 Giftakis J, 258 Haylock B, 855 Johnson RT, 1 Fedele E, 448 Gil AM, 365 Heils A, 866 Johnston MV, 305 Felderhoff-Mueser U, 50 Giladi N, 656 Heiss WD, 128 Jokic N, 553 Fenoglio C, 373 Gilboa A, 741 Hemm S, 738 Jones A, 634 Fernandez-Mata I, 762 Gill SS, 298 Henderson AJ, 883 Jones DK, 8 Ferrarese C, 373 Glaser M, 607 Hendriks -H, 505 Jones M, 444 Ferraris S, 921 Glass JD, 749 Hendrikse NH, 176 Jones SJ, 622 Ferrie CD, 327 Gleeson JG, 513, 934 Hensel A, 780 Josephs KA, 480 Feuer A, 148 Glorioso JC, 914 Herberger S, 607 Joyce KA, 855 Fezza F, 777 Glynn SM, 581, 610 Herholz K, 128 ffytche DH, 8 Goebel A, 463 Hernandez DG, 453 Kachergus J, 762 Fildes D, 855 Goebel I, 303 Hernandez J, 634 Kaji R, 309 Filla A, 777 Goetz CG, 144, 197 Hernandez MR, 119 Kalfakis N, 520 Finazzi-Agro A, 777 Gold R, 444 Herrlinger U, 843 Kalnins RM, 283 Fink DJ, 914 Goldman JE, 310 Heywood P, 298 Kamino K, 585 Finnegan K, 687 Gomez CM, 349 Hickman SJ, 622 Kamp C, 197 Fisch G, 695 Gomez Garre P, 634 Higuchi M, 832 Kang JH, 713 Fischbeck KH, 687, 749 Gémez-Hernandez JM, 749 Hill MD, 848 Kanno T, 168 Fischer R, 415 Gonzalez de Aguilar JL, Hirano M, 634, 921 Kanz L, 843 Fischl BR, 489 553 Hjaltason H, 765 Karagiozis H, 381 Fisone G, 17 Gorry PR, 795 Hoenicka J, 634 Karnath HO, 843 Fitzek S, 824 Gosselin I, 408 Hofer A, 535 Kasoff WS, 226 Fitzgerald-Bocarsly P, 813 Goto M, 604 Hofman A, 779, 789, 928 Kaspar BK, 649, 773 Flaster E, 252 Greenberg SA, 664 Holden KR, 608 Katsuno M, 236 FlieSbach K, 457 Gregory G, 139 Holloway L, 252 Kauppinen T, 82, 605 Floel A, 466 Gresch M, 866 Holzbaur ELF, 687 Kawas CH, 381 Floeter MK, 687 Gribaa M, 513, 934 Hopf HC, 824 Kawashima N, 918 12A_ Author Index Kayserili H, 513, 934 Leight S, 721 Mathieu J, 408 Nagorsen U, 466 Keers SM, 564 Leineweber B, 50 Matsuba Y, 832 Naidu S, 310 Kennedy J, 848 Leist TP, 526 Matsui T, 832 Nakao Y, 289 Kennedy WR, 687 Leite MI, 444 Mattheisen M, 866 Namekawa M, 567 Kersaitis C, 139 Lenzen KP, 866 Matthijs G, 933 Napolitano S, 777 Kessler J, 128 Leone M, 925 Mattson MP, 758 Narayan K, 813 Ketelsen UP, 148, 303 Lepar G, 139 Mayer RF, 468 Nascimbene C, 67, 304 Khosravani H, 745 Lesnick TG, 439 Mazzone P, 448 Nelson J, 98 Kieburtz K, 197 Levin MC, 932 McArthur JC, 163 Nemoto M, 832 Kiernan MC, 339 Lewis SJ, 564 McCullough ML, 104 NET-PD Investigators, 197 Kim DE, 34 Leys D, 472 McEntagart ME, 293, 609 Neubauer BA, 866 Kim HY, 571 Lezirovitz K, 730 McFarland H, 526 Neuro-Oncology Working Kimonis V, 457 Li CY, 768 McGeer PL, 161 Group, German Cancer Kirschner J, 148 ki Ly 823 McGowan JC, 355 Society, 843 Kirshner HS, 781 Le: @ 17 Mclnerney-Leo A, 453 Neville DCA, 156 Kivipelto M, 780 Li R, 310; 327 McIntosh AM, 283 Newsom-Davis J, 444 Klebe S, 567 Lian XY, 642 McKhann GM, 615 Nicolas V, 425, 609 Kleines M, 600 Liang GSL, 749 McNabb-Baltar J, 408 Niks EH, 444 Kleinschnitz C, 388 Liang Y, 236 McNaught TP, 704 Niogi SN, 355 Klutzny U, 591 Lichtner P, 535 McRory JE, 745 Nishimura A, 730 Knecht S, 466 Lin CSY, 339 Meggouh F, 589 Nishizawa M, 429 Knopman DS, 480 Lincoln SJ, 439 Mehta SG, 457 Niwa J, 236 Kobayashi Y, 236 Lino AMM, 730 Meininger V, 553 Nodera H, 309 Koenig M, 513, 934 Liu D, 758 Meitinger T, 535 Noorbakhsh F, 883 Kok F, 730 Lo EH, 571 Menchise V, 777 North KN, 42 Komiyama M, 918 Lochmiiller H, 415, 591 Mercimek-Mahmutoglu S, Nos C, 210 Kondo I, 585 Loeffler JP, 553 560 Niirnberg P, 866 Kopitzki K, 136 Loisel L, 408 Messer J, 513, 934 Nussbaum RL, 453 Kops GJ, 773 Lombardi R, 180 Messing A, 310, 327 Nyggard T, 634 Koralnik IJ, 576 Lonser RR, 542 Mesulam MM, 5, 204 Korinthenberg R, 148 Lopez de Munain A, 365 Meucci G, 304 Obata F, 918 Koroshetz WJ, 679 Lopez GJ, 453 Meyer-Lindenberg A, 453 Obladen M, 50 Kortekaas R, 176 Lorenz S, 866 Micklem K, 444 O’Brien WE, 557 Korteweg T, 606 Ludlow CL, 687 Middaugh LD, 795 Offenbacher H, 415 Kosaka K, 585 Lueck CJ, 904 Miki T, 585 Ogusu T, 168 Koudstaal PJ, 779, 789, Miller DH, 622 Oh SJ, 687 928 Ma Y, 596 Miller TM, 773 Oh U, 526 Kowa H, 918 Maccarrone M, 777 Mintz M, 749 Ohayon J, 526 Kremer BPH, 505 Macedo-Souza LI, 730 Misselwitz B, 388 Ohta E, 918 Kretzschmar HA, 607 Maddess T, 904 Miszkiel KA, 622 Ohtake H, 429 Kril JJ, 139 Mahler L, 50 Mitchell LA, 283 Oldfield EH, 542 Krishnan C, 67, 304 Maier C, 425, 609 Miyashita A, 429 Olsen DB, 754 Krystal JH, 226 Mamah CE, 439 Mizukami H, 832 Omran H, 303 Kubisch C, 303 Mancini P, 777 Moeller JR, 596 Onodera O, 429 Kugler SL, 464 Mancuso M, 921 Mohebbi MR, 608 O’Reilly EJ, 104 Kiiker W, 843 Mann EA, 687 Montalban X, 210 Orlacchio A, 448 Kuroda Y, 932 Maraganore DM, 439 Mont’Alverne F, 434 @rngreen MC, 60, 754 Kuwano R, 429 Maramattom BV, 581 Montgomery EB Jr., 157 Ortiz N, 396 Kwok JB, 139 Marchand L, 408 Montplaisir J, 277 Osorio I, 258 Marcus R, 252 Moore P, 721 Ostertag CB, 136 Labreuche J, 472 Markesbery W, 98 Mora CA, 526 Ouchi Y, 168 Labuda D, 408 Markianos M, 520 Morbin M, 180 Ozawa K, 832 Laing NG, 42 Marquardt T, 148 Morcos Y, 932 Lambert C, 564 Marsh SE, 513, 934 Moresco RM, 216 Pachner AR, 813 Landau WM, 465 Marti I, 365 Morgello S, 576 Pack AM, 252 Lanuza MA, 396 Marti-Masso JF, 365 Morgenstern LB, 160 Paisan-Ruiz C, 365 Launer L, 98 Martinelli V, 304 Moritz R, 444 Paisan-Ruiz C, 453 Lauria G, 180 Maruyama M, 832 Morrell MJ, 252 Pal DK, 464 Lava NS, 462 Marx A, 444 Moser HW, 307 Palermo MT, 381 Le W, 934 Marx JJ, 824 Motomura M, 289 Palesch YY, 197 Lee G, 874 Masaki K, 98 Mueller JC, 535 Palumbo V, 848 Lee JS, 874 Mash DC, 605 Muhle H, 866 Pan JW, 92 Lee PH, 874 Massicotte-Marquez J, 277 Muller A, 553 Panas M, 520 Lee SM, 932 Mata M, 914 Mungas D, 896 Papapetropoulos S, 605 Lee VMY, 721 Matarrese M, 216 Muramatsu S, 832 Pardo CA, 67, 304 Leenders KL, 176 Mathieu A, 277 Murray GJ, 542 Pareyson D, 180 Author Index 13A Parisi JE, 480 Rahman M, 604 Schofield PR, 139 Sullivan A, 883 Park P, 664 Rahman N, 293, 609 Schoser BGH, 591 Sumner CJ, 687 Parker DB, 745 Raiteri M, 448 Schréder R, 457 Sun RP, 111 Parkkinen L, 82, 605 Ramos-Alvarez M, 768 Schiitz A, 388 Sunderam S, 258 Pascual JM, 111 Randall A, 252 Schwamm LH, 679 Suzuki A, 495 Passini MA, 355 Ravina B, 197 Schwartz M, 60 Suzuki M, 429 Patel NK, 298 Ravindran S, 466 Schwenkreis P, 425, 609 Sveinbjornsdottir S, 765 Pauls K, 457 Ravizza T, 804 Scott CB, 704 Svendsen CN, 298 Pavese N, 634 Raymond D, 596 Scott JN, 848 Swoboda KJ, 704 Pawitan Y, 27 Reddy A, 310, 327 Seale C, 252 Sztriha L, 513, 934 Payami H, 462 Reid SL, 293, 609 Seidl R, 560 Pedersen NL, 27 Reyna SP, 704 Seilhean D, 553 Taguchi K, 585 Pelati O, 216 Riedel-Heller SG, 780 Sekine Y, 168 Tai YF, 634 Pelayo R, 210 Rio J, 210 Selcen D, 269 Takahashi H, 429 Pender MP, 158 Ritter K, 600 Sellhaus B, 600 Takahashi K, 92 Pepicelli O, 448 Rizzo M, 936 Selnes OA, 615 Takaki Y, 832 Peppe A, 448 Robinson R, 327 Shah K, 34 Takeda M, 585 Peracchi M, 304 Robl T, 415 Shane E, 252 Takeuchi H, 236 Perani D, 216 Rocca WA, 439 Shannon K, 197 Tanaka F, 236 Perego C, 804 Roddier K, 408 Sheikh KA, 768 Tang Y, 34 Peretz C, 656 Rojo A, 634 Shepherd CE, 139 Tanji H, 832 Pérez-Tur J, 365, 634 Rolf CM, 310 Sherwin RS, 226 Tanner CM, 197 Perry A, 119 Roller MJ, 349 Shimosegawa E, 495 Tauer U, 866 PPeersrcyh onR H,J , 586044 RRoosss RG, W6,3 4 98 SShiierbaeirsth iJ R,H , 31208 9 Tawil R, 664 Petersen RC, 480 Rotteveel JJ, 560 Sifringer M, 50 Tegenthoff M, 425, 609 Petit D, 277 Rottnek M, 576 Simon JE, 848 Téllez N, 210 Petrovitch H, 98 Rovira A, 210 Simpson D, 576 Terao S, 236 Piao YS, 429 Roy J, 848 Singhal AB, 571 Terry EC, 795 Piccini P, 634 Ruberg M, 567 Singleton AB, 453, 765 Teubner A, 600 Pico F, 472 Rudolf G, 866 Sinke RJ, 505 Thal DR, 457 Pierantozzi M, 448, 777 Ruitenberg A, 789 Smit LME, 327 Thiel A, 128 Smith DA, 156 Thomas N, 327 Pinkus GS, 664 Ruseckaite R, 904 Smith GE, 480 Thoémke F, 824 Pinkus JL, 664 Ruyle SZ, 310 Smith T, 855 Thompson AJ, 622 Pirttila T, 82, 605 Snutch TP, 745 Thompson CK, 204 Pisani A, 777 Sabaté MM, 396 Sobue G, 236 Thorburn DR, 921 Pizzinelli S, 304 Sacca F, 777 Sohn CH, 848 Thun MJ, 104 Plaha P, 298 Sacchetti M, 60 Sommer C, 388 Tiangyou W, 564 Plant GT, 622 Saenz A, 365 Song YJC, 139 Tilley BC, 197 Platt FM, 156 Sahoo T, 557 Sonneville R, 434 Timmer J, 136 Pleger B, 425, 609 Saido TC, 832 Sorensen AG, 679 Tintoré M, 210 Plotnik M, 656 Salat DH, 489 Soreq H, 741 Toft M, 762 PPPPPPPPPPoooooooooollltrntlwwllltkasemeaaehenerarkkya ons n ss t KOY PC ,,,,MR,C K ,A MH,6 72,58, ,14 0608134 481 3 874 649 10 567 SSSSSSSSSSaaaaaaaaaalnnsptnnlnpat oetdooika roemeuNifssrotA iédt rn,c eooH osiSTu ,Ml, n,9 a M C3s7G2D8,8 DD3, 3,6,S 0 2H6 , 3, 3615 96061645,36 4 ,49 3 2973 4 SSSSSSSSSSptptttttttareaee-eeerfocnDnvipaltkzeacnhnit innehaineoiiron gA nns ri Je A n G,A D, ,,AG UD ,P1,,S4,, 48 7 C4 0643,858 4300 0264 8 52689 ,6, 8 576777 TTTTTTTTTooosooorournmomouyjieijsbaoizytayoss u-na u hkESo liAa,awJ mT rN,s9a, l,kPT13 e iJ,89y, 68 H6 23, J1422 KQ67 ,8,24 98578 231 Pradat PF, 553 Scaglia F, 557 Stock M, 463 Tsujihata M, 289 Pratico D, 721 Scalabrino G, 304 Stéckler-Ipsiroglu $, 557 Tsutsui S, 883 Prineas JW, 158 Scaravilli F, 444 Stoessl AJ, 161 Tyor WR, 795 Prior TW, 704 Scarlato M, 373 Stoeter P, 824 Puls I, 687 Scarpini E, 373 Stoffers D, 157 Uhl M, 843 Pyle A, 564 Schaffer AA, 453 Stoll G, 388 Uitdehaag BMJ, 606 Schaffner SF, 258 Strain KJ, 439 Uitterlinden AG, 928 Qian J, 462 Scheffer IE, 465 Strauch K, 866 Umapathi P, 649 Quinlan R, 310 Scheithauer S, 600 Stringer JL, 642 Urban PP, 824 Quinzii C, 921 Scheper GC, 560 Strobel P, 444 Scheren-Wiemers N, 180 Strobl-Wildemann G, 415 Vaalburg W, 176 Rabins P, 936 Scherer SS, 749 Strupp M, 607 Vadlamudi L, 465 Ragert P, 425, 609 Schlotter-Weigel B, 415 Sueoka E, 932 Valente EM, 513, 738, 934 Rahimi F, 139 Schmitz B, 866 Sueoka N, 932 Vallée JN, 434 14A Author Index van de Warrenburg BPC, Volpini V, 549 Wetzel RD, 465 Yahyaoui M, 567 505 Vortmeyer AO, 542, 687 White L, 896 Yamagata HD, 585 Van Deerlin V, 721 White LR, 98, 762 Yamamoto M, 236 van der Knaap MS, 310, Wagner C, 557 Wieacker P, 148 Yamamoto T, 585 327, 560 Wagner K, 415 Wiggins CJ, 489 Yamanaka K, 773 van der Kouwe AJW, 489 Walbridge S, 542 Wiggins GC, 489 Yamano Y, 526 van Eck-Smit BLF, 157 Wald LL, 489 Wijdicks EFM, 581 Van Esch H, 933 Walker C, 855 Wilkinson SB, 258 Yang H, 111 van Meurs JBJ, 928 Wallace KE, 687 Willcox N, 444 Yang K, 34 van Oostrom JCH, 176 Waltz S, 866 Willemsen ATM, 176 Yirmiya R, 741 van Schaik IN, 589 Waltz SE, 883 Williams IM, 156 Yoshida M, 236 van Swieten JC, 789 Wan J, 131 Winblad B, 780 Yoshihara T, 236 van Zuijlen MCA, 505 Wang D, 111 Windpassinger C, 415 Yoshikawa E, 168 Vandenberghe RR, 204 Warnke PC, 136, 855 Winhuisen L, 128 Yoshimura T, 289 Vandenbulcke M, 204 Warren K, 883 Wirdefeldt K, 27 Yu GY, 349 Vangel MG, 679 Wasner C, 148 Wolf H, 780 Vargasa DL, 67, 304 Watts GDJ, 457 Wolfe D, 914 Vassilopoulos D, 520 Waxman SG, 785 Wolfe JH, 355 Zaldivar RA, 581 Vayssiere N, 738 Wehnert M, 148 Wolters EC, 157 Zamponi GW, 745 Vazquez, 634 Weinberg D, 144 Woods CG, 513, 934 Zarow C, 896 Vendette M, 277 Weiner MW, 896 Wooten GF, 197 Zatz M, 730 Vermeulen G, 560 Weintraub S, 204 Work M, 721 Zhang Z, 642 Vezzani A, 152, 609, 804 Weisskopf MG, 104 Wride MC, 704 Zhong W, 585 Vidailhet M, 613 Weissleder R, 34 Wrogemann K, 591 Zhou L, 144 Vidal L, 634 Weller M, 843 Wu L, 758 Zimmerman AW, 67, 304 Vincent A, 289, 444, 463 Weller RO, 310 Wu O, 679 Vinters HV, 896 Wendelschafer-Crabb G, Wiillner U, 535 Zimprich A, 535 Virgilio R, 373 687 Wiithrich C, 576 Zingler VC, 607 Vissing J, 60, 754 Werhahn KJ, 466 Zonderman AB, 381 Vite CH, 355 Wessellingh SL, 795 Xie TD, 349 Zuffi M, 216 Vogt MR, 98 Wessig C, 388 Xie W, 934 Zwick EB, 415 Author Index 15A serum lipids and hippocampal volume: the link to Alzhei- Subject Index mer’s disease? (Wolf et al) 2005;57:780 (Letter) vascular endothelial growth factor gene variability is asso- ciated with increased risk for AD (Del Bo et al) 2005; 57:373 N-acetyl aspartate Alzheimer’s disease, early interdependence of N-acetyl aspartate and high-energy cerebrospinal fluid neprilysin is reduced in prodromal Alz- phosphates in healthy human brain (Pan and Taka- heimer’s disease (Maruyama et al) 2005;57:832 hashi) 2005;57:92 Alzheimer’s disease, presenilin-1 Acetylcholine receptors Pick bodies in a family with presenilin-1 Alzheimer’s dis- acetylcholine receptors loss and postsynaptic damage in ease (Halliday et al) 2005;57:139 MuSK antibody—positive myasthenia gravis (Shiraishi et Alzheimer’s disease, prodromal al) 2005;57:289 cerebrospinal fluid neprilysin is reduced in prodromal Alz- Acetylcholinesterase inhibitors heimer’s disease (Maruyama et al) 2005;57:832 acetylcholinesterase inhibitors reduce brain and blood Alzheimer’s disease, variant interleukin-18 production (Pollak et al) 2005;57:741 a mutant PSENI/ causes dementia with Lewy bodies and Acute intermittent porphyria variant Alzheimer’s disease (Ishikawa et al) 2005;57:429 Amyotrophic lateral sclerosis acute intermittent porphyria presenting as a diffuse en- gene expression profile of spinal motor neurons in spo- cephalopathy (Maramattom et al) 2005;57:581 radic amyotrophic lateral sclerosis (Jiang et al) 2005;57: Acute motor axonal neuropathy 236 puffer fish poisoning, Guillain-Barré syndrome and persis- Nogo expression in muscle correlates with amyotrophic tent sodium channels (Kaji and Nodera) 2005;57:309 lateral sclerosis severity (Jokic et al) 2005;57:553 (Editorial) synergy of insulin-like growth factor-1 and exercise in Adaptive cortical plasticity amyotrophic lateral sclerosis (Kaspar et al) 2005;57:649 adaptive cortical plasticity in higher visual areas after acute virus-delivered small RNA silencing sustains strength in optic neuritis (Toosy et al) 2005;57:622 amyotrophic lateral sclerosis (Miller et al) 2005;57:773 Aerobic training vitamin E intake and risk of amyotrophic lateral sclerosis aerobic training in patients with myotonic dystrophy type (Ascherio et al) 2005;57:104 1 (Orngreen et al) 2005;57:754 Animal models Aging effective gene therapy for an inherited CNS disease in a fruit and vegetable consumption and cognitive decline in large animal model (Vite et al) 2005;57:355 aging women (Kang et al) 2005;57:713 murine gammaherpesvirus-68 infection of mice: a new Alexander disease model for human cerebral Epstein-Barr virus infection Alexander disease: combined gene analysis and MRI clarify (Hiusler et al) 2005;57:600 pathogenesis and extend phenotype (Moser) 2005;57: natural history of neurofibromatosis 1—associated optic 307 (Editorial) nerve glioma in mice (Bajenaru et al) 2005;57:119 glial fibrillary acidic protein mutations in infantile, juve- protective effects of ginseng components in a rodent nile, and adult forms of Alexander disease (Li et al) model of neurodegeneration (Lian et al) 2005;57:642 2005;57:310 RON-regulated innate immunity is protective in an ani- unusual variants of Alexander’s disease (van der Knaap et mal model of multiple sclerosis (Tsutsui et al) 2005;57: al) 2005;57:327 883 Alpers syndrome tumor necrosis factor-a inhibits seizures in mice via p75 POLG mutations and Alpers syndrome (Mancuso et al) receptors (Balosso et al) 2005;57:804 2005;57:921 Annals of Neurology Alzheimer’s disease message from the editor (Johnson) 2005;57:1 AD lesions and infarcts in demented and non-demented Antibodies Japanese-American men (Petrovitch et al) 2005;57:98 acetylcholine receptors loss and postsynaptic damage in cerebrospinal fluid profile in frontotemporal dementia and MuSK antibody—positive myasthenia gravis (Shiraishi et Alzheimer’s disease (Grossman et al) 2005;57:721 al) 2005;57:289 depressive symptoms, sex, and risk for Alzheimer’s disease changes in the neuromuscular synapse induced by an an- (Dal Forno et al) 2005;57:381 tibody against gangliosides (Santafé et al) 2005;57:396 identification of hippocampus-related candidate genes for fewer thymic changes in MuSK antibody-positive than in Alzheimer’s disease (Taguchi et al) 2005;57:585 MuSK antibody—negative MG (Leite et al) 2005;57:444 is Alzheimer’s disease preceded by neurodegeneration or intravenous immunoglobulin response and evidence for cerebral hypoperfusion (de la Torre) 2005;57:783 (Ed- pathogenic antibodies in a case of complex regional itorial) pain syndrome 1 (Goebel et al) 2005;57:463 (Letter) mitochondrial abnormalities in Alzheimer brain: mecha- Antiepileptic drugs nistic implications (Bubber et al) 2005;57:695 bone mass and turnover in women with epilepsy on anti- neuron number in Alzheimer’s disease and ischemic vas- epileptic drug monotherapy (Pack et al) 2005;57:252 cular dementia (Zarow et al) 2005;57:896 Anti—myelin-associated glycoprotein neuropathy serum lipids and hippocampal volume: the link to Alzhei- IgM deposits on skin nerves in anti-myelin-associated gly- mer’s disease? (den Heijer et al) 2005;57:779 (Letter) coprotein neuropathy (Lombardi et al) 2005;57:180 January issue, 1-160; February issue, 161-306; March issue, 307—468; April issue, 469-612; May issue, 613-782; June issue, 783-936. 16A © 2005 American Neurological Association Published by Wiley-Liss, Inc., through Wiley Subscription Services Aphasia, primary progressive Blood paradoxical features of word finding difficulty in primary acetylcholinesterase inhibitors reduce brain and blood progressive aphasia (Vandenberghe et al) 2005;57:204 interleukin-18 production (Pollak et al) 2005;57:741 Apraxia, oculomotor Blood-brain barrier very late onset in ataxia oculomotor apraxia type | (Cris- blood-brain barrier dysfunction in parkinsonian midbrain cuolo et al) 2005;57:777 (Letter) in vivo (Kortekaas et al) 2005;57:176 Arterial dolichoectasia Bone mass intracranial arterial dolichoectasia and small-vessel disease bone mass and turnover in women with epilepsy on anti- in stroke patients (Pico et al) 2005;57:472 epileptic drug monotherapy (Pack et al) 2005;57:252 Arteriopathy, dilatative Bone mineral density dilatative arteriopathy (dolichoectasia): what is know and bone mass and turnover in women with epilepsy on anti- not known (Caplan) 2005;57:469 (Editorial) epileptic drug monotherapy (Pack et al) 2005;57:252 Ataxia Book reviews fragile X—associated tremor/ataxia syndrome in sisters re- Clinical Neurophysiology Volume I, Revised and Enlarged lated to X-inactivation (Berry-Kravis et al) 2005;57:144 Edition: EMG, Nerve Conduction, and Evoked Potentials, mutations in senataxin responsible for Quebec cluster of edited by Binnie et al (Mayer) 2005;57:468 ataxia with neuropathy (Duquette et al) 2005;57:408 Complex Worlds from Simpler Nervous Systems, edited by nonconsensus intronic mutations cause episodic ataxia Bradford (Rizzo) 2005;57:936 (Wan et al) 2005;57:131 Epilepsy and the Ketogenic Diet, edited by Stafstrom and should we screen for FMRI premutations in female sub- Rho (Johnston) 2005;57:305 jects presenting with ataxia? (Van Esch et al) 2005;57: Essays in Social Neuroscience, edited by Cacioppo and 933 (Letter) Berntson (Rabins) 2005;57:936 Ataxia, spinocerebellar Handbook of Stroke Prevention in Clinical Practice, edited age at onset variance analysis in spinocerebellar ataxias: a by Furie and Kelly (Morgenstern) 2005;57:160 study in a Dutch-French cohort (van de Warrenburg et Magnetic Resonance in Epilepsy: Neuroimaging Techniques, al) 2005;57:505 2nd ed, by Kuzniecky and Jackson (Glynn and Cascino) false-positive SCA8 gene test in a patient with pathologi- 2005;57:610 cally proven multiple system atrophy (Factor et al) The Neuropathology of Dementia, 2nd ed, edited by Esiri et 2005;57:462 (Letter) al (Crain) 2005;57:610 giant SCA8 alleles in nine children whose mother has two -alliative Care in Neurology, by Voltz et al (Jacobson) moderately large ones (Corral et al) 2005;57:549 2005;57:468 spinocerebellar ataxia type 26 maps to chromosome Restless Legs Syndrome, edited by Chaudhuri et al (Earley) 19p13.3 adjacent to SCAG (Yu et al) 2005;57:349 2005;57:781 Ataxia with oculomotor apraxia type I Review of Aphasia and Related Neurogenic Language Disor- very late onset in ataxia oculomotor apraxia type | (Cris- ders, 3rd ed, edited by LaPointe (Kirshner) 2005;57:781 cuolo et al) 2005;57:777 (Letter) Atrophy, multiple system Textbook of Diabetic Neuropathy, edited by Gries et al (Cornblath) 2005;57:160 false-positive SCA8 gene test in a patient with pathologi- cally proven multiple systém atrophy (Factor et al) Vision and Seeing: It’s Not What You Think, by Pylyshyn 2005;57:462 (Letter) (Duffy) 2005;57:305 Autism Brain neuroglial activation and neuroinflammation in the brain acetylcholinesterase inhibitors reduce brain and blood of patients with autism (Vargas et al) 2005;57:67, interleukin-18 production (Pollak et al) 2005;57:741 2005;57:304 (Correction) AD lesions and infarcts in demented and non-demented Autoimmunity Japanese-American men (Petrovitch et al) 2005;57:98 autoimmunity to heterogeneous nuclear ribonucleopro- interdependence of N-acetyl aspartate and high-energy teins in neurological disease (Levin et al) 2005;57:932 phosphates in healthy human brain (Pan and Taka- (Letter) hashi) 2005;57:92 autoimmunity to heterogeneous nuclear ribonucleoproteins mitochondrial abnormalities in Alzheimer brain: mecha- in neurological disease (Sueoka et al) 2005;57:932 (Reply) nistic implications (Bubber et al) 2005;57:695 Axonal Guillain-Barré syndrome neuroglial activation and neuroinflammation in the brain overlap of pathology in paralytic rabies and axonal of patients with autism (Vargas et al) 2005;57:67, Guillain-Barré syndrome (Sheikh et al) 2005;57:768 2005;57:304 (Correction) Brain development caspase-1—processed interleukins in hyperoxia-induced cell Basque families death in the developing brain (Felderhoff-Mueser et al) familial Parkinson’s disease: clinical and genetic analysis 2005;57:50 of four Basque families (Paisan-Ruiz et al) 2005;57: Brain infarction 365 transient ischemic attack with infarction: a unique syn- Berardinelli-Seip congenital lipodystrophy gene 2 drome? (Ay et al) 2005;57:679 phenotypes of the N88S Berardinelli-Seip congenital lipo- Brain infarction, acute dystrophy 2 mutation (Auer-Grumbach et al) 2005;57: metabolic penumbra of acute brain infarction: a correlation 415 with infarct growth (Shimosegawa et al) 2005;57:495 Biopsy, skin Brain tumors another tool for the neurologist’s toolbox (McArthur and essential language function of the right hemisphere in Griffin) 2005;57:163 (Editorial) brain tumor patients (Thiel et al) 2005;57:128 Subject Index 17A Brainstem Cerebrospinal fluid somatotopic organization of the corticospinal tract in the cerebrospinal fluid neprilysin is reduced in prodromal Alz- human brainstem: a MRI-based mapping analysis heimer’s disease (Maruyama et al) 2005;57:832 (Marx et al) 2005;57:824 cerebrospinal fluid profile in frontotemporal dementia and Bulbar muscular atrophy Alzheimer’s disease (Grossman et al) 2005;57:721 distal spinal and bulbar muscular atrophy caused by dyn- high endogenous cannabinoid levels in the cerebrospinal actin mutation (Puls et al) 2005;57:687 fluid of untreated Parkinson’s disease patients (Pisani et N-Butyldeoxynojirimycin al) 2005;57:777 (Letter) NSAIDs increase survival in the Sandhoff disease mouse: high tumor necrosis factor-a levels in cerebrospinal fluid synergy with N-butyldeoxynojirimycin (Jeyakumar et of cobalamin-deficient patients (Scalabrino et al) 2005; al) 2005;57:156 (Correction) 57:304 (Correction) Bypass surgery Cerebrovascular lesions neurocognitive complications after coronary artery bypass AD lesions and infarcts in demented and non-demented surgery (Selnes and McKhann) 2005;57:615 Japanese-American men (Petrovitch et al) 2005;57:98 Charcot-Marie-Tooth disease Calcium channel mutations early onset neuropathy in a compound form of Charcot- effects of Ca,3.2 channel mutations linked to idiopathic Marie-Tooth disease (Meggouh et al) 2005;57:589 generalized epilepsy (Khosravani et al) 2005;57:745 Chemokine ligand CXCL13 Cannabinoids the nervous system as ectopic germinal center: CXCL13 high endogenous cannabinoid levels in the cerebrospinal and IgG in Lyme neuroborreliosis (Narayan et al) 2005; fluid of untreated Parkinson’s disease patients (Pisani et 57:813 al) 2005;57:777 (Letter) Chromosome 19p13.3 Capillaries spinocerebellar ataxia type 26 maps to chromosome capillary physiology and drug delivery in central nervous 19p13.3 adjacent to SCA6 (Yu et al) 2005;57:349 system lymphomas (Warnke et al) 2005;57:136 Chromosome 1q31.1 Carnitine palmitoyltransferase 2 gene (CPT2) genetic linkage of autosomal dominant progressive su- fuel utilization in subjects with carnitine palmitoyltrans- pranuclear palsy to 1q31.1 (Ros et al) 2005;57:634 ferase 2 gene mutations (Orngreen et al) 2005;57:60 Chromosome 11q13 Caspase-1 spastic paraplegia, optic atrophy, and neuropathy is linked to caspase-1—processed interleukins in hyperoxia-induced cell chromosome 11q13 (Macedo-Souza et al) 2005;57:730 death in the developing brain (Felderhoff-Mueser et al) Chromosome 12q23-q24 2005;57:50 confirmation of a hereditary motor and sensory neuropa- Caveolin-3 gene (CAV3) thy IIC locus at chromosome 12q23-q24 (McEntagart autosomal recessive rippling muscle disease with homozy- et al) 2005;57:293, 2005;57:609 (Correction) gous CAV3 mutations (Kubisch et al) 2005;57:303 Cobalamin deficiency (Letter) high tumor necrosis factor-a levels in cerebrospinal fluid Cell death of cobalamin-deficient patients (Scalabrino et al) 2005; caspase-1—processed interleukins in hyperoxia-induced cell 57:304 (Correction) death in the developing brain (Felderhoff-Mueser et al) Cognitive decline 2005;57:50 fruit and vegetable consumption and cognitive decline in Central nervous system lymphoma aging women (Kang et al) 2005;57:713 capillary physiology and drug delivery in central nervous Combined methylmalonic aciduria and homocystinuria system lymphomas (Warnke et al) 2005;57:136 creatine metabolism in combined methylmalonic aciduria NOA-03 multicenter trial of high-dose methotrexate ther- and homocystinuria (Bodamer et al) 2005;57:557 apy in primary central nervous system lymphoma: final Complex regional pain syndrome report (Herrlinger et al) 2005;57:843 sensorimotor returning in complex regional pain syn- Cerebral cortex drome parallels pain reduction (Pleger et al) 2005;57: imaging connectivity in the human cerebral cortex: the 425, 2005;57:669 (Correction) next frontier? (Mesulam) 2005;57:5 (Editorial) Complex regional pain syndrome 1 Cerebral Epstein-Barr virus infection intravenous immunoglobulin response and evidence for murine gammaherpesvirus-68 infection of mice: a new pathogenic antibodies in a case of complex regional model for human cerebral Epstein-Barr virus infection pain syndrome 1 (Goebel et al) 2005;57:463 (Letter) (Hausler et al) 2005;57:600 Connectivity Cerebral fat embolism imaging connectivity in the human cerebral cortex: the cerebral fat embolism: usefulness of magnetic resonance next frontier? (Mesulam) 2005;57:5 (Editorial) spectroscopy (Guillevin et al) 2005;57:434 Connexin32 Cerebral hypoperfusion severe neuropathy with leaky connexin32 hemichannels cerebral hypoperfusion and clinical onset of dementia: the (Liang et al) 2005;57:749 Rotterdam study (Ruitenberg et al) 2005;57:789 Convection perfusion is Alzheimer’s disease preceded by neurodegeneration or convection perfusion of glucocerebrosidase for neurono- cerebral hypoperfusion (de la Torre) 2005;57:783 (Ed- pathic Gaucher’s disease (Lonser et al) 2005;57:542 itorial) Coronary artery bypass surgery Cerebral ischemia, focal neurocognitive complications after coronary artery bypass neuroprotection by the PGE, EP2 receptor in permanent surgery (Selnes and McKhann) 2005;57:615 focal cerebral ischemia (Liu et al) 2005;57:758 Cortex normobaric hyperoxia extends the reperfusion window in extracellular metabolites in the cortex and hippocampus of focal cerebral ischemia (Kim et al) 2005;57:571 epileptic patients (Cavus et al) 2005;57:226 18A Subject Index Cortical plasticity intracranial arterial dolichoectasia and small-vessel disease adaptive cortical plasticity in higher visual areas after acute in stroke patients (Pico et al) 2005;57:472 optic neuritis (Toosy et al) 2005;57:622 Dopa-responsive dystonia Corticospinal tract the metabolic pathology of dopa-responsive dystonia somatotopic organization of the corticospinal tract in the (Asanuma et al) 2005;57:596 human brainstem: a MRI-based mapping analysis Dopamine (Marx et al) 2005;57:824 microglial activation and dopamine terminal loss in early Creatine Parkinson’s disease (Ouchi et al) 2005;57:168 creatine metabolism in combined methylmalonic aciduria Dopamine receptors and homocystinuria (Bodamer et al) 2005;57:557 increased D, dopamine receptor signaling in levodopa- Creutzfeldt-Jakob disease induced dyskinesia (Aubert et al) 2005;57:17 upbeat nystagmus as the initial clinical sign of Creutzfeldt- Drug delivery Jakob disease (Zingler et al) 2005;57:607 (Letter) capillary physiology and drug delivery in central nervous Cyclic guanosine monophosphate system lymphomas (Warnke et al) 2005;57:136 subthalamic stimulation activates internal pallidus: evi- convection perfusion of glucocerebrosidase for neurono- dence from cGMP microdialysis in PD patients (Stefani pathic Gaucher’s disease (Lonser et al) 2005;57:542 et al) 2005;57:448 Drug resistance deep brain stimulation to relieve severe drug-resistant Deep brain stimulation SUNCT (Leone et al) 2005;57:925 deep brain stimulation for dystonia: make the lame walk Drugs, nonsteroidal antiinflammater (Vidailhet and Pollak) 2005;57:613 (Editorial) NSAIDs increase survival in the Sandhoff disease mouse: deep brain stimulation to relieve severe drug-resistant synergy with N-butyldeoxynojirimycin (Jeyakumar et SUNCT (Leone et al) 2005;57:925 al) 2005;57:156 (Correction) pallidal stimulation improves pantothenate kinase—associ- Dynactin ated neurodegeneration (Castelnau et al) 2005;57:738 distal spinal and bulbar muscular atrophy caused by dyn- subthalamic stimulation activates internal pallidus: evi- actin mutation (Puls et al) 2005;57:687 dence from cGMP microdialysis in PD patients (Stefani Dyskinesia et al) 2005;57:448 increased D, dopamine receptor signaling in levodopa- Dementia induced dyskinesia (Aubert et al) 2005;57:17 AD lesions and infarcts in demented and non-demented Dystonia Japanese-American men (Petrovitch et al) 2005;57:98 deep brain stimulation for dystonia: make the lame walk cerebral nypoperfusion and clinical onset of dementia: the (Vidailhet and Pollak) 2005;57:613 (Editorial) Rotterdam study (Ruitenberg et al) 2005;57:789 Dystonia, dopa-responsive plasma testosterone in male patients with Huntington’s the metabolic pathology of dopa-responsive dystonia disease: relations to severity of illness and dementia (Asanuma et al) 2005;57:596 (Markianos et al) 2005;57:520 Dystonia, idiopathic a-synuclein pathology does not predict extrapyramidal torsin A haplotype predisposes to idiopathic dystonia (Cla- symptoms or dementia (Parkkinen et al) 2095;57:82 rimon et al) 2005;57:765 Dementia, frontotemporal cerebrospinal fluid profile in frontotemporal dementia and Early onset neuropathy Alzheimer’s disease (Grossman et al) 2005;57:721 early onset neuropathy in a compound form of Charcot- mutant valosin-containing protein causes a novel type of Marie-Tooth disease (Meggouh et al) 2005;57:589 frontotemporal dementia (Schréder et al) 2005;57:457 Editorials Dementia, vascular Alexander disease: combined gene analysis and MRI clarify correlates of hippocampal in Alzheimer’s disease and isch- pathogenesis and extend phenotype (Moser) 2005;57: emic vascular dementia (Zarow et al) 2005;57:896 307 Dementia with Lewy bodies another tool for the neurologist’s toolbox (McArthur and a mutant PSENI causes dementia with Lewy bodies and Griffin) 2005;57:163 variant Alzheimer’s disease (Ishikawa et al) 2005;57:429 deep brain stimulation for dystonia: make the lame walk Depressive symptoms (Vidailhet and Pollak) 2005;57:613 depressive symptoms, sex, and risk for Alzheimer’s disease dilatative arteriopathy (dolichoectasia): what is know and (Dal Forno et al) 2005;57:381 not known (Caplan) 2005;57:469 Dermatomyositis hot spots: can positron emission tomography offer insights interferon-a/B—mediated innate immune mechanisms in into the pathogenesis of PD? (Stoess! and McGeer) dermatomyositis (Greenberg et al) 2005;57:664 2005;57:160 Diffuse encephalopathy imaging connectivity in the human cerebral cortex: the acute intermittent porphyria presenting as a diffuse en- next frontier? (Mesulam) 2005;57:5 cephalopathy (Maramattom et al) 2005;57:581 is Alzheimer’s disease preceded by neurodegeneration or Dilatative arteriopathy cerebral hypoperfusion (de la Torre) 2005;57:783 dilatative arteriopathy (dolichoectasia): what is know and puffer fish poisoning, Guillain-Barré syndrome and persis- not known (Caplan) 2005;57:469 (Editorial) tent sodium channels (Kaji and Nodera) 2005;57:309 Distal spinal and bulbar muscular atrophy Electrical stimulation distal spinal and bulbar muscular atrophy caused by dyn- automated seizure abatement in humans using electrical actin mutation (Puls et al) 2005;57:687 stimulation (Osorio et al) 2005;57:258 Dolichoectasia Encephalitis dilatative arteriopathy (dolichoectasia): what is know and highly active antiretroviral therapy and human immuno- not known (Caplan) 2005;57:469 (Editorial) deficiency virus encephalitis (Cook et al) 2005;57:795 Subject Index 19A Encephalopathy, diffuse Freezing of gait acute intermittent porphyria presenting as a diffuse en- is freezing of gait in Parkinson’s disease related to asym- cephalopathy (Maramattom et al) 2005;57:581 metric motor function (Plotnik et al) 2005;57:656 Entorhinal layer II Fright detection of entorhinal layer II using Tesla magnetic res- fright is a provoking factor in vanishing white matter dis- onance imaging (Augustinack et al) 2005;57:489 ease (Vermeulen et al) 2005;57:560 Epidermal growth factor Frontotemporal dementia high tumor necrosis factor-a levels in cerebrospinal fluid cerebrospinal fluid profile in frontotemporal dementia and of cobalamin-deficient patients (Scalabrino et al) 2005; Alzheimer’s disease (Grossman et al) 2005;57:721 57:304 (Correction) mutant valosin-containing protein causes a novel type of Epilepsy frontotemporal dementia (Schréder et al) 2005;57:457 bone mass and turnover in women with epilepsy on anti- Frontotemporal lobe degeneration epileptic drug monotherapy (Pack et al) 2005;57:252 antemortem diagnosis of frontotemporal lobar degenera- extracellular metabolites in the cortex and hippocampus of tion (Knopman et al) 2005;57:480 epileptic patients (Cavus et al) 2005;57:226 glucose metabolism and serotonin receptors in the fronto- Epilepsy, idiopathic generalized temporal lobe degeneration (Franceschi et al) 2005;57: effects of Ca,3.2 channel mutations linked to idiopathic 216 generalized epilepsy (Khosravani et al) 2005;57:745 Fruit and vegetable consumption genetic dissection of photosensitivity and its relation to id- fruit and vegetable consumption and cognitive decline in iopathic generalized epilepsy (Tauer et al) 2005;57:866 aging women (Kang et al) 2005;57:713 Epilepsy, rolandic Futility studies genetic influence on rolandic epilepsy (Bali et al) 2005;57: a responsive outcome for Parkinson’s disease neuroprotec- 464 (Letter) tion futility studies (Elm et al) 2005;57:197 genetic influence on rolandic epilepsy (Vadlamudi et al) 2005;57:465 (Reply) Gadofluorine M Epilepsy, temporal lobe assessment of nerve degeneration by gadofluorine M-—en- bilateral limbic diffusion abnormalities in unilateral tem- hanced magnetic resonance imaging (Bendszus et al) poral lobe epilepsy (Concha et al) 2005;57:188 2005;57:388 Episodic ataxia Gait, freezing of nonconsensus intronic mutations cause episodic ataxia is freezing of gait in Parkinson’s disease related to asym- (Wan et al) 2005;57:131 metric motor function (Plotnik et al) 2005;57:656 Epstein-Barr virus infection Gangliosides murine gammaherpesvirus-68 infection of mice: a new changes in the neuromuscular synapse induced by an an- model for human cerebral Epstein-Barr virus infection tibody against gangliosides (Santafé et al) 2005;57:396 (Hausler et al) 2005;57:600 Gaucher’s disease Erythromelalgia convection perfusion of glucocerebrosidase for neurono- erythromelalgia: a hereditary pain syndrome enters the pathic Gaucher’s disease (Lonser et al) 2005;57:542 molecular era (Waxman and Dib-Hajj) 2005;57:785 Gene expression profiles Exercise gene expression profile of spinal motor neurons in spo- synergy of insulin-like growth factor-1 and exercise in radic amyotrophic lateral sclerosis (Jiang et al) 2005;57: amyotrophic lateral sclerosis (Kaspar et al) 2005;57:649 236 Extracellular metabolites Gene therapy extracellular metabolites in the cortex and hippocampus of effective gene therapy for an inherited CNS disease in a epileptic patients (Cavus et al) 2005;57:226 large animal model (Vite et al) 2005;57:355 Extrapyramidal symptoms virus-delivered small RNA silencing sustains strength in a-synuclein pathology does not predict extrapyramidal symptoms or dementia (Parkkinen et al) 2005;57:82 amyotrophic lateral sclerosis (Miller et al) 2005;57:773 Gene transfer Familial Parkinson’s disease gene transfer of glutamic acid decarboxylase reduces neu- familial Parkinson’s disease: clinical and genetic analysis of ropathic pain (Hao et al) 2005;57:914 four Basque families (Paisan-Ruiz et al) 2005;57:365 Genes Fat embolism identification of hippocampus-related candidate genes for cerebral fat embolism: usefulness of magnetic resonance Alzheimer’s disease (Taguchi et al) 2005;57:585 spectroscopy (Guillevin et al) 2005;57:434 Genetics Febrile seizures distinguishing the four genetic causes of Jouberts syndro- interleukin-18 and febrile seizures: from bench to bedside me-related disorders (Valente et al) 2005;57:513 (Mohebbi and Holden) 2005;57:608 (Letter) familial Parkinson’s disease: clinical and genetic analysis of interleukin-18 contributes to the generation of experimen- four Basque families (Paisan-Ruiz et al) 2005;57:365 tal febrile seizures (Dubé et al) 2005;57:152, 2005;57: genetic and clinical identification of Parkinson’s disease 609 (Correction) patients with LRRK2 G2019S mutation (Deng et al) FMRI premutation screening 2005;57:934 (Letter) should we screen for FMRI premutations in female sub- genetic dissection of photosensitivity and its relation to id- jects presenting with ataxia? (Van Esch et al) 2005;57: iopathic generalized epilepsy (Tauer et al) 2005;57:866 933 (Letter) genetic influence on rolandic epilepsy (Bali et al) 2005;57: Fragile X-associated tremor/ataxia syndrome 464 (Letter) fragile X—associated tremor/ataxia syndrome in sisters re- genetic influence on rolandic epilepsy (Vadlamudi et al) lated to X-inactivation (Berry-Kravis et al) 2005;57:144 2005;57:465 (Reply) 20A Subject Index

See more

The list of books you might like

Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.
DMCA & Copyright: Dear all, most of the website is community built, users are uploading hundred of books everyday, which makes really hard for us to identify copyrighted material, please contact us if you want any material removed.
Copyright @ PDFdrive.to, 2022 | We love our users